Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	phosphopyruvate hydratase activity	ENO1 ENO2 ENO3	4.11e-06	4	203	3	GO:0004634
GeneOntologyMolecularFunction	extracellular matrix structural constituent	IMPG1 HMCN2 HSPG2 FRAS1 COL12A1 COL17A1 TGFBI HMCN1 VCAN MUC6	2.35e-05	188	203	10	GO:0005201
GeneOntologyCellularComponent	phosphopyruvate hydratase complex	ENO1 ENO2 ENO3	3.64e-06	4	204	3	GO:0000015
GeneOntologyCellularComponent	basement membrane	HMCN2 USH2A HSPG2 FRAS1 COL17A1 TGFBI HMCN1	1.98e-04	122	204	7	GO:0005604
GeneOntologyCellularComponent	external encapsulating structure	IMPG1 HMCN2 AGT USH2A HSPG2 FRAS1 COL12A1 COL17A1 COL20A1 PKHD1L1 TGFBI CELA3B CELA3A HMCN1 VCAN ADAMTS14 MUC6	2.63e-04	658	204	17	GO:0030312
GeneOntologyCellularComponent	distal axon	MAP1A PTPRF KCNC1 KCNC3 PTPRS USH2A MICAL1 PNMT BRSK2 SLC18A2 SMO ENO1 ENO2	3.64e-04	435	204	13	GO:0150034
GeneOntologyCellularComponent	neuronal cell body	MAP1A STAU1 DLGAP3 HMCN2 PTPRF KCNC1 KCNC3 PTPRS VPS13A USH2A PNMT RTN4 ATP13A2 RGS12 MTOR SLC18A2 SMO WDFY3 ENO2	5.59e-04	835	204	19	GO:0043025
GeneOntologyCellularComponent	extracellular matrix	IMPG1 HMCN2 AGT USH2A HSPG2 FRAS1 COL12A1 COL17A1 COL20A1 TGFBI CELA3B CELA3A HMCN1 VCAN ADAMTS14 MUC6	7.41e-04	656	204	16	GO:0031012
GeneOntologyCellularComponent	collagen-containing extracellular matrix	IMPG1 HMCN2 AGT USH2A HSPG2 FRAS1 COL12A1 COL17A1 COL20A1 TGFBI CELA3B CELA3A HMCN1 VCAN	7.42e-04	530	204	14	GO:0062023
GeneOntologyCellularComponent	DNA helicase complex	BLM HELQ	9.30e-04	5	204	2	GO:0033202
GeneOntologyCellularComponent	somatodendritic compartment	ABL2 MAP1A MARK3 ADCY9 STAU1 DLGAP3 HMCN2 PTPRF KCNC1 KCNC3 PTPRS VPS13A USH2A HTR1D PNMT RTN4 ATP13A2 RGS12 MTOR SLC18A2 MARK4 SMO WDFY3 ENO2	9.35e-04	1228	204	24	GO:0036477
Domain	Ig-like_fold	IGFN1 BTNL8 MYCBP2 CADM4 PHYHIP TMEM81 FNDC1 FNDC7 HMCN2 PTPRF PTPRS NFKB2 USH2A PLXNA1 HSPG2 COL12A1 CD300LF COL20A1 MYOM3 RELA VSTM2B ADGRA2 PKHD1L1 HMCN1 VCAN IL4R	4.02e-08	706	200	26	IPR013783
Domain	-	IGFN1 BTNL8 MYCBP2 CADM4 PHYHIP TMEM81 FNDC1 FNDC7 PTPRF PTPRS NFKB2 USH2A PLXNA1 HSPG2 COL12A1 CD300LF COL20A1 MYOM3 RELA VSTM2B ADGRA2 PKHD1L1 HMCN1 VCAN IL4R	4.77e-08	663	200	25	2.60.40.10
Domain	Enolase_N	ENO1 ENO2 ENO3	1.21e-06	3	200	3	PF03952
Domain	Enolase	ENO1 ENO2 ENO3	1.21e-06	3	200	3	IPR000941
Domain	Enolase_C	ENO1 ENO2 ENO3	1.21e-06	3	200	3	IPR020810
Domain	Enolase_N	ENO1 ENO2 ENO3	1.21e-06	3	200	3	IPR020811
Domain	Enolase_CS	ENO1 ENO2 ENO3	1.21e-06	3	200	3	IPR020809
Domain	Enolase_C	ENO1 ENO2 ENO3	1.21e-06	3	200	3	PF00113
Domain	DAPK1	DAPK2 DAPK1 DAPK3	1.21e-06	3	200	3	IPR020676
Domain	Enolase_N	ENO1 ENO2 ENO3	1.21e-06	3	200	3	SM01193
Domain	Enolase_C	ENO1 ENO2 ENO3	1.21e-06	3	200	3	SM01192
Domain	ENOLASE	ENO1 ENO2 ENO3	1.21e-06	3	200	3	PS00164
Domain	MFS_dom	SLC17A2 SPNS1 UNC93A SLC22A20P SLC2A9 FLVCR2 SLC17A5 SLC17A1 SLC18A2 MFSD13A	1.83e-06	134	200	10	IPR020846
Domain	-	ENO1 ENO2 ENO3	4.80e-06	4	200	3	3.30.390.10
Domain	-	ENO1 ENO2 ENO3	4.80e-06	4	200	3	3.20.20.120
Domain	Enolase_C-like	ENO1 ENO2 ENO3	4.80e-06	4	200	3	IPR029065
Domain	Enolase_N-like	ENO1 ENO2 ENO3	4.80e-06	4	200	3	IPR029017
Domain	FN3	IGFN1 PHYHIP FNDC1 FNDC7 PTPRF PTPRS USH2A COL12A1 COL20A1 MYOM3 IL4R	5.12e-06	185	200	11	SM00060
Domain	fn3	IGFN1 PHYHIP FNDC1 FNDC7 PTPRF PTPRS USH2A COL12A1 COL20A1 MYOM3	9.98e-06	162	200	10	PF00041
Domain	FN3	IGFN1 PHYHIP FNDC1 FNDC7 PTPRF PTPRS USH2A COL12A1 COL20A1 MYOM3 IL4R	1.03e-05	199	200	11	PS50853
Domain	FN3_dom	IGFN1 PHYHIP FNDC1 FNDC7 PTPRF PTPRS USH2A COL12A1 COL20A1 MYOM3 IL4R	1.62e-05	209	200	11	IPR003961
Domain	MFS	SLC17A2 SPNS1 SLC22A20P SLC2A9 FLVCR2 SLC17A5 SLC17A1 SLC18A2	2.12e-05	108	200	8	PS50850
Domain	VWFA	ITGB3 HMCN2 VWA3A COL12A1 COL20A1 HMCN1 CACNA2D3	2.80e-05	82	200	7	PS50234
Domain	VWA	ITGB3 HMCN2 VWA3A COL12A1 COL20A1 HMCN1 CACNA2D3	3.28e-05	84	200	7	SM00327
Domain	VWF_A	ITGB3 HMCN2 VWA3A COL12A1 COL20A1 HMCN1 CACNA2D3	9.42e-05	99	200	7	IPR002035
Domain	ZF_CCHC_HIVEP	HIVEP1 HIVEP3	1.14e-04	2	200	2	PS51811
Domain	-	ITGB3 VWA3A COL12A1 COL20A1 HMCN1 CACNA2D3	1.41e-04	74	200	6	3.40.50.410
Domain	MFS_1	SLC17A2 SPNS1 FLVCR2 SLC17A5 SLC17A1 SLC18A2	1.76e-04	77	200	6	PF07690
Domain	MFS	SLC17A2 SPNS1 FLVCR2 SLC17A5 SLC17A1 SLC18A2	1.76e-04	77	200	6	IPR011701
Domain	IPT	NFKB2 PLXNA1 RELA PKHD1L1	1.85e-04	27	200	4	SM00429
Domain	IG	IGFN1 BTNL8 CADM4 TMEM81 HMCN2 PTPRF PTPRS HSPG2 CD300LF MYOM3 VSTM2B ADGRA2 HMCN1 VCAN	1.86e-04	421	200	14	SM00409
Domain	Ig_sub	IGFN1 BTNL8 CADM4 TMEM81 HMCN2 PTPRF PTPRS HSPG2 CD300LF MYOM3 VSTM2B ADGRA2 HMCN1 VCAN	1.86e-04	421	200	14	IPR003599
Domain	EGF_CA	FAT2 HEG1 HMCN2 HSPG2 CUBN HMCN1 VCAN	3.45e-04	122	200	7	SM00179
Domain	IPT	NFKB2 PLXNA1 RELA PKHD1L1	3.63e-04	32	200	4	IPR002909
Domain	EGF-like_Ca-bd_dom	FAT2 HEG1 HMCN2 HSPG2 CUBN HMCN1 VCAN	3.80e-04	124	200	7	IPR001881
Domain	Laminin_G	FAT2 USH2A HSPG2 COL12A1 COL20A1	3.87e-04	58	200	5	IPR001791
Domain	SEA	IMPG1 HSPG2 MUC16	4.04e-04	14	200	3	SM00200
Domain	EGF	ITGB3 FAT2 HEG1 HSPG2 CUBN HMCN1 VCAN	4.19e-04	126	200	7	PF00008
Domain	GPCR_2_secretin-like	ADGRG4 FZD9 ADGRA2 ADGRG2 SMO	4.54e-04	60	200	5	IPR000832
Domain	GPCR_2-like	ADGRG4 FZD9 ADGRA2 ADGRG2 SMO	4.54e-04	60	200	5	IPR017981
Domain	G_PROTEIN_RECEP_F2_4	ADGRG4 FZD9 ADGRA2 ADGRG2 SMO	4.90e-04	61	200	5	PS50261
Domain	-	ADGRG4 FAT2 USH2A HSPG2 COL12A1 WDFY3	5.51e-04	95	200	6	2.60.120.200
Domain	G2F	HMCN2 HMCN1	6.75e-04	4	200	2	PF07474
Domain	MARK/par1	MARK3 MARK4	6.75e-04	4	200	2	IPR033624
Domain	NIDOGEN_G2	HMCN2 HMCN1	6.75e-04	4	200	2	PS50993
Domain	K_chnl_volt-dep_Kv3	KCNC1 KCNC3	6.75e-04	4	200	2	IPR003974
Domain	GFP	HMCN2 HMCN1	6.75e-04	4	200	2	IPR009017
Domain	G2_nidogen/fibulin_G2F	HMCN2 HMCN1	6.75e-04	4	200	2	IPR006605
Domain	IG_LIKE	IGFN1 BTNL8 CADM4 TMEM81 HMCN2 PTPRF PTPRS HSPG2 CD300LF MYOM3 VSTM2B ADGRA2 HMCN1 VCAN	8.59e-04	491	200	14	PS50835
Domain	Ca/CaM-dep_Ca-dep_prot_Kinase	MARK3 DAPK2 DAPK3 BRSK2 MARK4	8.64e-04	69	200	5	IPR020636
Domain	Ig_I-set	IGFN1 CADM4 HMCN2 PTPRF PTPRS HSPG2 MYOM3 HMCN1	1.04e-03	190	200	8	IPR013098
Domain	I-set	IGFN1 CADM4 HMCN2 PTPRF PTPRS HSPG2 MYOM3 HMCN1	1.04e-03	190	200	8	PF07679
Domain	Ig-like_dom	IGFN1 BTNL8 CADM4 TMEM81 HMCN2 PTPRF PTPRS HSPG2 CD300LF MYOM3 VSTM2B ADGRA2 HMCN1 VCAN	1.08e-03	503	200	14	IPR007110
Domain	KA1	MARK3 MARK4	1.12e-03	5	200	2	PF02149
Domain	IPT_NFkappaB	NFKB2 RELA	1.12e-03	5	200	2	IPR033926
Domain	KA1_dom	MARK3 MARK4	1.12e-03	5	200	2	IPR001772
Domain	RHD_CS	NFKB2 RELA	1.12e-03	5	200	2	IPR030492
Domain	KA1	MARK3 MARK4	1.12e-03	5	200	2	PS50032
Domain	-	MARK3 MARK4	1.12e-03	5	200	2	3.30.310.80
Domain	EGF-like_dom	IMPG1 FAT2 HEG1 HMCN2 HSPG2 FRAS1 CUBN HMCN1 VCAN	1.49e-03	249	200	9	IPR000742
Domain	SEA	IMPG1 HSPG2 MUC16	1.60e-03	22	200	3	PF01390
Domain	EGF_1	ITGB3 FAT2 HEG1 HMCN2 USH2A HSPG2 CUBN HMCN1 VCAN	1.76e-03	255	200	9	PS00022
Domain	SEA	IMPG1 HSPG2 MUC16	1.83e-03	23	200	3	PS50024
Domain	SEA_dom	IMPG1 HSPG2 MUC16	1.83e-03	23	200	3	IPR000082
Domain	APC_su10/DOC_dom	MYCBP2 HERC2	2.31e-03	7	200	2	IPR004939
Domain	DOC	MYCBP2 HERC2	2.31e-03	7	200	2	PS51284
Domain	KA1/Ssp2_C	MARK3 MARK4	2.31e-03	7	200	2	IPR028375
Domain	ANAPC10	MYCBP2 HERC2	2.31e-03	7	200	2	PF03256
Domain	APC10	MYCBP2 HERC2	2.31e-03	7	200	2	SM01337
Domain	ConA-like_dom	BTNL8 ADGRG4 FAT2 USH2A HSPG2 COL12A1 COL20A1 WDFY3	2.54e-03	219	200	8	IPR013320
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	MYCBP2 PFAS MBD6 ARHGEF11 ADCY9 HEG1 PTPRF PTPRS NFKB2 MLLT6 HERC2 MCF2L PLXNA1 ABCC10 HSPG2 FRAS1 DOCK9 AOC2 HECTD4 MYOM3 ADGRA2 ATP13A2 KCNH3 HIVEP3 ARAP3 TRIB3 MTOR FURIN MARK4 WDFY3 IL4R RAB11FIP3	1.09e-13	1105	205	32	35748872
Pubmed	The death-associated protein kinases: structure, function, and beyond.	DAPK2 DAPK1 DAPK3	2.02e-07	3	205	3	16756490
Pubmed	The role of STAT3/mTOR-regulated autophagy in angiotensin II-induced senescence of human glomerular mesangial cells.	STAT3 AGT MTOR	2.02e-07	3	205	3	30389500
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	CCDC8 CTNNAL1 MYCBP2 TRPS1 DAPK3 PFAS ADCY9 BLM PTPRF PTPRS VPS13A HERC2 RELA NIBAN2 ARHGAP5 FAM171A2 WDR11 SLC4A1AP AIFM1 KCTD3 UBR3 SSH2	3.05e-07	1049	205	22	27880917
Pubmed	A Moonlighting Human Protein Is Involved in Mitochondrial Import of tRNA.	ENO1 ENO2 ENO3	8.04e-07	4	205	3	25918939
Pubmed	Interferon induces NF-kappa B-inducing kinase/tumor necrosis factor receptor-associated factor-dependent NF-kappa B activation to promote cell survival.	NFKB2 MAP3K14 RELA	8.04e-07	4	205	3	16009713
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	CCDC8 HIVEP1 ABL2 MYCBP2 MARK3 DAPK2 DAPK3 STAT3 RUSC2 WDR62 MAP3K14 BRSK2 RGS12 FAM171A2 MTOR SLC25A1 MARK4 SSH2 PATJ	9.69e-07	861	205	19	36931259
Pubmed	The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.	ENDOD1 MARK3 CADM4 DAPK1 ADCY9 PTPRF PLXNA1 COL17A1 EPB41L4B DOCK9 NIBAN2 RGS12 FAM171A2 MTOR PATJ	1.67e-06	569	205	15	30639242
Pubmed	A new member of the I kappaB protein family, I kappaB epsilon, inhibits RelA (p65)-mediated NF-kappaB transcription.	NFKB2 NFKBIE RELA	2.00e-06	5	205	3	9315679
Pubmed	Genetic variation in the nuclear factor kappaB pathway in relation to susceptibility to rheumatoid arthritis.	NFKB2 NFKBIE MAP3K14 RELA	2.02e-06	16	205	4	18434448
Pubmed	Proteomics analysis of cardiac extracellular matrix remodeling in a porcine model of ischemia/reperfusion injury.	HSPG2 FRAS1 COL20A1 TGFBI HMCN1 VCAN	2.20e-06	64	205	6	22261194
Pubmed	Roles of tau protein in health and disease.	MAP1A MARK3 BRSK2 MTOR MARK4	3.77e-06	40	205	5	28386764
Pubmed	Cathepsin X cleaves the C-terminal dipeptide of alpha- and gamma-enolase and impairs survival and neuritogenesis of neuronal cells.	ENO1 ENO2 ENO3	3.98e-06	6	205	3	19433310
Pubmed	Control of RelB during dendritic cell activation integrates canonical and noncanonical NF-κB pathways.	NFKB2 NFKBIE RELA	3.98e-06	6	205	3	23086447
Pubmed	Expression of mouse dchs1, fjx1, and fat-j suggests conservation of the planar cell polarity pathway identified in Drosophila.	DCHS2 FAT2 DCHS1	6.94e-06	7	205	3	16059920
Pubmed	Hiv-1 Tat can substantially enhance the capacity of NIK to induce IkappaB degradation.	NFKB2 MAP3K14 RELA	6.94e-06	7	205	3	11511100
Pubmed	Leukocyte antigen-related protein tyrosine phosphatase negatively regulates hydrogen peroxide-induced vascular smooth muscle cell apoptosis.	STAT3 PTPRF ENO1	6.94e-06	7	205	3	18854310
Pubmed	Regulator of G protein signaling 12 drives inflammatory arthritis by activating synovial fibroblasts through MYCBP2/KIF2A signaling.	MYCBP2 HERC2 RGS12	6.94e-06	7	205	3	36700049
Pubmed	Molecular reclassification of Crohn's disease by cluster analysis of genetic variants.	IRGM STAT3 HERC2 DNAH12	9.51e-06	23	205	4	20886065
Pubmed	Integral and associated lysosomal membrane proteins.	SPNS1 ABCC10 ATP13A2 SLC17A5 WDR11 MTOR ENPEP	1.04e-05	126	205	7	17897319
Pubmed	Abnormal morphogenesis but intact IKK activation in mice lacking the IKKalpha subunit of IkappaB kinase.	NFKB2 NFKBIE RELA	1.11e-05	8	205	3	10195896
Pubmed	Nanog maintains pluripotency of mouse embryonic stem cells by inhibiting NFkappaB and cooperating with Stat3.	STAT3 NFKB2 RELA	1.65e-05	9	205	3	18223644
Pubmed	Genetic risk profiling and prediction of disease course in Crohn's disease patients.	IRGM STAT3 HERC2 DNAH12	2.15e-05	28	205	4	19422935
Pubmed	Regulation of NF-κB by the p105-ABIN2-TPL2 complex and RelAp43 during rabies virus infection.	NFKB2 NFKBIE RELA	2.35e-05	10	205	3	29084252
Pubmed	Extracellular matrix remodelling in response to venous hypertension: proteomics of human varicose veins.	HMCN2 AGT HSPG2 COL12A1 LCN2 TGFBI VCAN	2.71e-05	146	205	7	27068509
Pubmed	Comparison of tear protein levels in breast cancer patients and healthy controls using a de novo proteomic approach.	MROH7 MCF2L LCN2 SSH2 ENO1 ENO2 ENO3	3.09e-05	149	205	7	22664934
Pubmed	Common polymorphisms influencing serum uric acid levels contribute to susceptibility to gout, but not to coronary artery disease.	SLC17A2 SLC2A9 SLC17A1	3.22e-05	11	205	3	19890391
Pubmed	Boldine suppresses dextran sulfate sodium-induced mouse experimental colitis: NF-κB and IL-6/STAT3 as potential targets.	STAT3 RELA	3.46e-05	2	205	2	26891685
Pubmed	Motor dysfunction and altered synaptic transmission at the parallel fiber-Purkinje cell synapse in mice lacking potassium channels Kv3.1 and Kv3.3.	KCNC1 KCNC3	3.46e-05	2	205	2	12930807
Pubmed	Role of crosstalk between STAT3 and mTOR signaling in driving sensitivity to chemotherapy in osteosarcoma cell lines.	STAT3 MTOR	3.46e-05	2	205	2	33448097
Pubmed	Excessive STAU1 condensate drives mTOR translation and autophagy dysfunction in neurodegeneration.	STAU1 MTOR	3.46e-05	2	205	2	38913026
Pubmed	Kv3.3 subunits control presynaptic action potential waveform and neurotransmitter release at a central excitatory synapse.	KCNC1 KCNC3	3.46e-05	2	205	2	35510987
Pubmed	Attenuation of EPO-dependent erythroblast formation by death-associated protein kinase-2.	DAPK2 DAPK1	3.46e-05	2	205	2	18535204
Pubmed	Phosphoproteomic analysis reveals hyperactivation of mTOR/STAT3 and LCK/Calcineurin axes in pediatric early T-cell precursor ALL.	STAT3 MTOR	3.46e-05	2	205	2	28082737
Pubmed	Glycyrrhizic acid inhibits leukemia cell growth and migration via blocking AKT/mTOR/STAT3 signaling.	STAT3 MTOR	3.46e-05	2	205	2	26191214
Pubmed	Lack of angiotensin II conversion to angiotensin III increases water but not alcohol consumption in aminopeptidase A-deficient mice.	AGT ENPEP	3.46e-05	2	205	2	16889841
Pubmed	Subcellular localization of the voltage-gated potassium channels Kv3.1b and Kv3.3 in the cerebellar dentate nucleus of glutamic acid decarboxylase 67-green fluorescent protein transgenic mice.	KCNC1 KCNC3	3.46e-05	2	205	2	18682278
Pubmed	Roles of STAT3 in protein secretion pathways during the acute-phase response.	STAT3 RELA	3.46e-05	2	205	2	23460517
Pubmed	Pegylated IFN-α suppresses hepatitis C virus by promoting the DAPK-mTOR pathway.	DAPK1 MTOR	3.46e-05	2	205	2	27930338
Pubmed	Nuclear translocation of STAT3 and NF-κB are independent of each other but NF-κB supports expression and activation of STAT3.	STAT3 RELA	3.46e-05	2	205	2	28089769
Pubmed	HUPO BPP pilot study: a proteomics analysis of the mouse brain of different developmental stages.	ENO1 ENO2	3.46e-05	2	205	2	17922513
Pubmed	NF-κB inducing kinase is a therapeutic target for systemic lupus erythematosus.	MAP3K14 RELA	3.46e-05	2	205	2	29330524
Pubmed	Importance of the alternative NF-κB activation pathway in inflammation-associated gastrointestinal carcinogenesis.	NFKB2 RELA	3.46e-05	2	205	2	27102559
Pubmed	Effects of the curly tail genotype on neuroepithelial integrity and cell proliferation during late stages of primary neurulation.	HSPG2 GRHL3	3.46e-05	2	205	2	11787818
Pubmed	Effects of mTOR-STAT3 on the migration and invasion abilities of hepatoma cell and mTOR-STAT3 expression in liver cancer.	STAT3 MTOR	3.46e-05	2	205	2	25063062
Pubmed	SF3B3-regulated mTOR alternative splicing promotes colorectal cancer progression and metastasis.	SF3B3 MTOR	3.46e-05	2	205	2	38671459
Pubmed	Unconventional p65/p52 NF-κB module regulates key tumor microenvironment-related genes in breast tumor-associated macrophages (TAMs).	NFKB2 RELA	3.46e-05	2	205	2	39278618
Pubmed	Ablation of Kv3.1 and Kv3.3 potassium channels disrupts thalamocortical oscillations in vitro and in vivo.	KCNC1 KCNC3	3.46e-05	2	205	2	18495891
Pubmed	TRIB3 Interacts with STAT3 to Promote Cancer Angiogenesis.	STAT3 TRIB3	3.46e-05	2	205	2	36245025
Pubmed	NF-κB RelA Is Required for Hepatoprotection during Pneumonia and Sepsis.	STAT3 RELA	3.46e-05	2	205	2	31160364
Pubmed	Complete structure of the human gene encoding neuron-specific enolase.	ENO1 ENO2	3.46e-05	2	205	2	2045099
Pubmed	Persistent Activation of NF-κB in BRCA1-Deficient Mammary Progenitors Drives Aberrant Proliferation and Accumulation of DNA Damage.	BRCA1 NFKB2	3.46e-05	2	205	2	27292187
Pubmed	ANG II activates effectors of mTOR via PI3-K signaling in human coronary smooth muscle cells.	AGT MTOR	3.46e-05	2	205	2	15317677
Pubmed	Isolation of murine neuron-specific and non-neuronal enolase cDNA clones.	ENO1 ENO2	3.46e-05	2	205	2	3801001
Pubmed	Spinocerebellar ataxia-13 Kv3.3 potassium channels: arginine-to-histidine mutations affect both functional and protein expression on the cell surface.	KCNC1 KCNC3	3.46e-05	2	205	2	23734863
Pubmed	HIPK2 directs cell type-specific regulation of STAT3 transcriptional activity in Th17 cell differentiation.	STAT3 HIPK2	3.46e-05	2	205	2	35344430
Pubmed	Biochemical characterization of the mouse muscle-specific enolase: developmental changes in electrophoretic variants and selective binding to other proteins.	ENO1 ENO3	3.46e-05	2	205	2	9169614
Pubmed	Stage-dependent therapeutic efficacy in PI3K/mTOR-driven squamous cell carcinoma of the skin.	MTOR GRHL3	3.46e-05	2	205	2	29238073
Pubmed	Purkinje-cell-restricted restoration of Kv3.3 function restores complex spikes and rescues motor coordination in Kcnc3 mutants.	KCNC1 KCNC3	3.46e-05	2	205	2	18448641
Pubmed	Integrin beta3 Leu33Pro polymorphism increases BRCA1-associated ovarian cancer risk.	ITGB3 BRCA1	3.46e-05	2	205	2	17220212
Pubmed	Allele-dependent changes of olivocerebellar circuit properties in the absence of the voltage-gated potassium channels Kv3.1 and Kv3.3.	KCNC1 KCNC3	3.46e-05	2	205	2	15217387
Pubmed	Expanding the Interactome of the Noncanonical NF-κB Signaling Pathway.	NFKB2 MAP3K14	3.46e-05	2	205	2	27416764
Pubmed	NF-κB inducing kinase, a central signaling component of the non-canonical pathway of NF-κB, contributes to ovarian cancer progression.	NFKB2 MAP3K14	3.46e-05	2	205	2	24533079
Pubmed	Within the hemopoietic system, LAR phosphatase is a T cell lineage-specific adhesion receptor-like protein whose phosphatase activity appears dispensable for T cell development, repertoire selection and function.	PTPRF PAX5	3.46e-05	2	205	2	11241288
Pubmed	Alcohol hypersensitivity, increased locomotion, and spontaneous myoclonus in mice lacking the potassium channels Kv3.1 and Kv3.3.	KCNC1 KCNC3	3.46e-05	2	205	2	11517255
Pubmed	Identification of a novel class of elastase isozyme, human pancreatic elastase III, by cDNA and genomic gene cloning.	CELA3B CELA3A	3.46e-05	2	205	2	2826474
Pubmed	Hepatocyte-specific mutation of both NF-κB RelA and STAT3 abrogates the acute phase response in mice.	STAT3 RELA	3.46e-05	2	205	2	22466650
Pubmed	Tetrandrine suppresses β‑glucan‑induced macrophage activation via inhibiting NF‑κB, ERK and STAT3 signaling pathways.	STAT3 RELA	3.46e-05	2	205	2	27121946
Pubmed	Presynaptic Kv3 channels are required for fast and slow endocytosis of synaptic vesicles.	KCNC1 KCNC3	3.46e-05	2	205	2	33508244
Pubmed	Ser289 phosphorylation activates both DAPK1 and DAPK2 but in response to different intracellular signaling pathways.	DAPK2 DAPK1	3.46e-05	2	205	2	31116076
Pubmed	Distribution of serum neuron-specific enolase and the establishment of a population reference interval in healthy adults.	ENO1 ENO2	3.46e-05	2	205	2	30779465
Pubmed	Sodium butyrate-induced DAPK-mediated apoptosis in human gastric cancer cells.	DAPK2 DAPK1	3.46e-05	2	205	2	22160140
Pubmed	Kv3 potassium channels control the duration of different arousal states by distinct stochastic and clock-like mechanisms.	KCNC1 KCNC3	3.46e-05	2	205	2	16553620
Pubmed	Receptor-mediated induction of aminopeptidase A (APA) of human glomerular epithelial cells (HGEC) by glucocorticoids.	AGT ENPEP	3.46e-05	2	205	2	1756856
Pubmed	Genetic Analysis of Human Chymotrypsin-Like Elastases 3A and 3B (CELA3A and CELA3B) to Assess the Role of Complex Formation between Proelastases and Procarboxypeptidases in Chronic Pancreatitis.	CELA3B CELA3A	3.46e-05	2	205	2	27999401
Pubmed	Serum CA125 and NSE: biomarkers of disease severity in patients with silicosis.	MUC16 ENO2	3.46e-05	2	205	2	24642341
Pubmed	Differential expression of muscle-specific enolase in embryonic and fetal myogenic cells during mouse development.	ENO1 ENO3	3.46e-05	2	205	2	2090519
Pubmed	NIK promotes tissue destruction independently of the alternative NF-κB pathway through TNFR1/RIP1-induced apoptosis.	NFKB2 MAP3K14	3.46e-05	2	205	2	26045047
Pubmed	mTOR mediates human trophoblast invasion through regulation of matrix-remodeling enzymes and is associated with serine phosphorylation of STAT3.	STAT3 MTOR	3.46e-05	2	205	2	19331815
Pubmed	Behavioral motor dysfunction in Kv3-type potassium channel-deficient mice.	KCNC1 KCNC3	3.46e-05	2	205	2	16923152
Pubmed	Accumulation of p100, a precursor of NF-κB2, enhances osteoblastic differentiation in vitro and bone formation in vivo in aly/aly mice.	NFKB2 MAP3K14	3.46e-05	2	205	2	22282470
Pubmed	The prognostic values of CA125, CA19.9, NSE, AND SCC for stage I NSCLC are limited.	MUC16 ENO2	3.46e-05	2	205	2	22674301
Pubmed	Tribbles homolog 3 attenuates mammalian target of rapamycin complex-2 signaling and inflammation in the diabetic kidney.	TRIB3 MTOR	3.46e-05	2	205	2	24676635
Pubmed	HIPK2 mediates M1 polarization of microglial cells via STAT3: A new mechanism of depression-related neuroinflammation.	STAT3 HIPK2	3.46e-05	2	205	2	36924038
Pubmed	[Association of single nucleotide polymorphisms of CSPG2 and HSPG2 genes with intracranial aneurysm in ethnic Han Chinese population].	HSPG2 VCAN	3.46e-05	2	205	2	23568740
Pubmed	Pals-associated tight junction protein functionally links dopamine and angiotensin II to the regulation of sodium transport in renal epithelial cells.	AGT PATJ	3.46e-05	2	205	2	19563532
Pubmed	Molecular cloning of complementary DNA encoding one of the human pancreatic protease E isozymes.	CELA3B CELA3A	3.46e-05	2	205	2	2460440
Pubmed	Nucleotide sequences of cDNAs alpha and gamma enolase mRNAs from mouse brain.	ENO1 ENO2	3.46e-05	2	205	2	2362815
Pubmed	Peptidylarginine deiminase modulates the physiological roles of enolase via citrullination: links between altered multifunction of enolase and neurodegenerative diseases.	ENO1 ENO2	3.46e-05	2	205	2	22551201
Pubmed	[STAT3 and NF-κB is activated in papillary thyroid carcinoma tissues].	STAT3 RELA	3.46e-05	2	205	2	27667468
Pubmed	Increased motor drive and sleep loss in mice lacking Kv3-type potassium channels.	KCNC1 KCNC3	3.46e-05	2	205	2	15005717
Pubmed	An epithelial Nfkb2 pathway exacerbates intestinal inflammation by supplementing latent RelA dimers to the canonical NF-κB module.	NFKB2 RELA	3.46e-05	2	205	2	34155144
Pubmed	Physical and functional interactions between STAT3 and ZIP kinase.	DAPK3 STAT3	3.46e-05	2	205	2	16219639
Pubmed	Mammalian target of rapamycin inhibitors, temsirolimus and torin 1, attenuate stemness-associated properties and expression of mesenchymal markers promoted by phorbol-myristate-acetate and oncostatin-M in glioblastoma cells.	STAT3 MTOR	3.46e-05	2	205	2	28351321
Pubmed	Mammalian hemicentin 1 is assembled into tracks in the extracellular matrix of multiple tissues.	HMCN2 HMCN1	3.46e-05	2	205	2	32035013
Pubmed	Epigenetic induction of lipocalin 2 expression drives acquired resistance to 5-fluorouracil in colorectal cancer through integrin β3/SRC pathway.	ITGB3 LCN2	3.46e-05	2	205	2	34588619
Pubmed	A hepatocyte-specific transcriptional program driven by Rela and Stat3 exacerbates experimental colitis in mice by modulating bile synthesis.	STAT3 RELA	3.46e-05	2	205	2	39137024
Pubmed	Rescue of motor coordination by Purkinje cell-targeted restoration of Kv3.3 channels in Kcnc3-null mice requires Kcnc1.	KCNC1 KCNC3	3.46e-05	2	205	2	20016089
Pubmed	Schisandrin A reverses doxorubicin-resistant human breast cancer cell line by the inhibition of P65 and Stat3 phosphorylation.	STAT3 RELA	3.46e-05	2	205	2	29181822
Pubmed	Collagen XVII Shedding Suppresses Re-Epithelialization by Directing Keratinocyte Migration and Dampening mTOR Signaling.	COL17A1 MTOR	3.46e-05	2	205	2	26827763
Interaction	TOP3B interactions	MYCBP2 PSENEN PFAS MBD6 ARHGEF11 ADCY9 STAU1 HEG1 PTPRF PTPRS NFKB2 MLLT6 HERC2 MCF2L PLXNA1 ABCC10 HSPG2 FRAS1 DOCK9 AOC2 HECTD4 MYOM3 ADGRA2 ATP13A2 KCNH3 HIVEP3 ARAP3 TRIB3 MTOR FURIN MARK4 WDFY3 IL4R DDX28 RAB11FIP3	1.26e-06	1470	201	35	int:TOP3B
GeneFamily	Ankyrin repeat domain containing\|Death associated protein kinases	DAPK2 DAPK1 DAPK3	4.69e-06	5	142	3	1021
GeneFamily	Fibronectin type III domain containing	IGFN1 FNDC1 FNDC7 PTPRF PTPRS USH2A COL12A1 COL20A1 MYOM3	4.86e-06	160	142	9	555
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	IGFN1 HMCN2 PTPRF PTPRS HSPG2 MYOM3 HMCN1	2.83e-04	161	142	7	593
GeneFamily	Solute carriers	SLC17A2 SLC41A3 SLC22A20P SLC25A42 SLC2A9 SLC13A3 FLVCR2 SLC17A5 SLC17A1 SLC18A2 SLC25A1	2.91e-04	395	142	11	752
GeneFamily	Cadherin related	DCHS2 FAT2 DCHS1	2.98e-04	17	142	3	24
GeneFamily	Ankyrin repeat domain containing\|NF-kappa B complex subunits	NFKB2 RELA	6.03e-04	5	142	2	1254
GeneFamily	Adhesion G protein-coupled receptors, subfamily G	ADGRG4 ADGRG2	1.25e-03	7	142	2	917
GeneFamily	Fibulins	HMCN2 HMCN1	1.66e-03	8	142	2	556
GeneFamily	G protein-coupled receptors, Class F frizzled	FZD9 SMO	3.22e-03	11	142	2	286
GeneFamily	Potassium voltage-gated channels	KCNC1 KCNC3 KCNH3	3.79e-03	40	142	3	274
GeneFamily	Immunoglobulin like domain containing	CADM4 TMEM81 HMCN2 HSPG2 MYOM3 ADGRA2	4.22e-03	193	142	6	594
Coexpression	NABA_CORE_MATRISOME	IMPG1 FNDC1 FNDC7 HMCN2 USH2A VWA3A HSPG2 FRAS1 COL12A1 COL17A1 COL20A1 TGFBI HMCN1 VCAN	3.52e-08	275	203	14	M5884
Coexpression	NABA_CORE_MATRISOME	IMPG1 FNDC1 FNDC7 HMCN2 VWA3A HSPG2 FRAS1 COL12A1 COL17A1 COL20A1 TGFBI HMCN1 VCAN	2.09e-07	270	203	13	MM17057
Coexpression	LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2	TRPS1 VPS13A FRAS1 SLC2A9 SLC13A3 CUBN SLC17A1 WDFY3 PATJ ENPEP RAB11FIP3	1.33e-06	221	203	11	M39222
Coexpression	KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3	CTNNAL1 MARK3 BNC1 FAT2 PTPRF WDR89 COL12A1 COL17A1 RTN4 MAP3K14 NIBAN2 RGS12 EEF2KMT TGFBI AIFM1 FURIN WDFY3 GRHL3 ENO1 IL4R	9.79e-06	843	203	20	M2356
Coexpression	GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_PPARG_KO_TREG_CD4_TCELL_DN	PFAS MBD6 DLGAP3 MTA3 SLC25A42 MUC16 NSUN3 FURIN	1.33e-05	139	203	8	M8948
Coexpression	LINDVALL_IMMORTALIZED_BY_TERT_DN	BLM FNDC1 HSPG2 ARHGAP5 VCAN ENO2	2.22e-05	73	203	6	M1561
Coexpression	MILI_PSEUDOPODIA_HAPTOTAXIS_DN	ENDOD1 SPNS1 HEG1 PTPRF PTPRS NFKB2 NFKBIE ABHD1 PLXNA1 WDR62 HSPG2 RTN4 PIGU ADGRA2 SF3B3 MIGA2 IL4R	2.48e-05	681	203	17	M5314
Coexpression	GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_MAC_DN	STAU1 HEG1 NFKB2 SCN9A ABCC10 RELA ARHGAP5 SLC18A2 MUC6	2.66e-05	199	203	9	M5242
Coexpression	GSE22103_UNSTIM_VS_LPS_STIM_NEUTROPHIL_UP	HIVEP1 MLLT6 EXOSC3 RELA NIBAN2 NUP35 HIVEP3 MARK4 IL4R	2.76e-05	200	203	9	M7794
Coexpression	MILI_PSEUDOPODIA_HAPTOTAXIS_DN	ENDOD1 SPNS1 HEG1 PTPRF PTPRS NFKB2 NFKBIE ABHD1 PLXNA1 WDR62 HSPG2 RTN4 PIGU ADGRA2 SF3B3 MIGA2 IL4R	3.68e-05	703	203	17	MM1055
Coexpression	NABA_MATRISOME	IMPG1 FNDC1 FNDC7 HMCN2 AGT USH2A PLXNA1 VWA3A HSPG2 FRAS1 COL12A1 COL17A1 COL20A1 MUC16 TGFBI CELA3B CELA3A HMCN1 VCAN ADAMTS14 MUC6	5.14e-05	1026	203	21	M5889
Coexpression	RASHI_RESPONSE_TO_IONIZING_RADIATION_2	HIVEP1 STAT3 NFKB2 HIPK2 RELA LCN2 TRIB3	5.56e-05	125	203	7	M5888
Coexpression	GSE6269_HEALTHY_VS_STAPH_PNEUMO_INF_PBMC_DN	MAP1A ARHGEF11 COL17A1 FLVCR2 LCN2 FURIN VCAN WDFY3	5.66e-05	170	203	8	M5649
Coexpression	RASHI_RESPONSE_TO_IONIZING_RADIATION_2	HIVEP1 STAT3 NFKB2 HIPK2 RELA LCN2 TRIB3	6.14e-05	127	203	7	MM1113
ToppCell	BAL-Mild-cDC_0\|Mild / Compartment, Disease Groups and Clusters	ABL2 ADCY9 DLGAP3 PTPRF TOMM40L SNX32 CD300LF PIGU FURIN VCAN	4.65e-09	163	205	10	7047d3ba847930f42a6d5f71e18d49f3071c6409
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DAPK2 DAPK1 PTPRF FHIP1A HSPG2 FRAS1 FLVCR2 DENND3 PATJ CACNA2D3	1.27e-08	181	205	10	b45b11428d13950369347e051d4d517efb2bd4fd
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DAPK1 RIPOR3 MCF2L FRAS1 SUSD4 COL12A1 HIPK2 RGS12 PATJ CACNA2D3	1.34e-08	182	205	10	eb138aa1dca9373f1586600f258df06dcf56d81f
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DAPK2 DAPK1 PTPRF FHIP1A HSPG2 FRAS1 FLVCR2 DENND3 PATJ CACNA2D3	1.65e-08	186	205	10	3aebe163799109ffc67e4e10ee47c2dd0886a92c
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC17A2 AADACL2 USH2A VWA3A FRAS1 COL12A1 PKHD1L1 HMCN1 CACNA2D3	5.90e-08	160	205	9	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC17A2 AADACL2 USH2A VWA3A FRAS1 COL12A1 PKHD1L1 HMCN1 CACNA2D3	5.90e-08	160	205	9	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	Control-Epithelial_alveolar-AT_1-Differentiating_AT1\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DAPK2 DAPK1 FHIP1A HSPG2 FRAS1 FLVCR2 DENND3 PATJ CACNA2D3	1.40e-07	177	205	9	9af14a056eb6d88c6f11b09f6d4c0d3448d647d5
ToppCell	LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DAPK2 DAPK1 PTPRF FHIP1A HSPG2 FRAS1 NIBAN2 PATJ CACNA2D3	1.95e-07	184	205	9	42ce855b4f8475a8298192feec785bdc69bc5bb0
ToppCell	343B-Epithelial_cells-Epithelial-I_(AT1)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	DAPK2 FNDC1 HEG1 PLXNA1 HSPG2 COL12A1 TRGV9 DENND3 ADGRG2	1.95e-07	184	205	9	c7073d1b2c4fdb154d87678b92a0629c02116972
ToppCell	343B-Epithelial_cells-Epithelial-I_(AT1)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	DAPK2 FNDC1 HEG1 PLXNA1 HSPG2 COL12A1 TRGV9 DENND3 ADGRG2	1.95e-07	184	205	9	1ed558a88215b248431c524ea16f13d9022ae98c
ToppCell	facs-Brain_Non-Myeloid-Cerebellum\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PHYHIP FAT2 FNDC7 KCNC1 KCNC3 SYT13 LCN2 PATJ ENO2	2.04e-07	185	205	9	c083a4974590b9ed3ecafedd3e9cdebc5047fe39
ToppCell	facs-Trachea-18m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l54\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CTNNAL1 RIPOR3 TMEM81 TC2N SUSD4 DOCK9 LCN2 PKHD1L1 ARAP3	2.04e-07	185	205	9	59acaf025353405948dc34ccccf37ec5c08ea903
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ADCY9 MCF2L SLC25A42 SLC2A9 SLC13A3 CUBN SLC17A1 ENPEP RAB11FIP3	2.14e-07	186	205	9	5784d255e9ca449d375d81938d0fbbd8a7eb44f6
ToppCell	COVID-19-kidney-Mito-rich_PCT\|kidney / Disease (COVID-19 only), tissue and cell type	AGT SLC2A9 MYOM3 SLC13A3 CUBN SLC17A1 PATJ ENPEP RAB11FIP3	2.24e-07	187	205	9	738ec2611b4be6a08eedad16b57fba84e1f11fef
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SLC25A42 SLC2A9 MYOM3 SLC13A3 CUBN SLC17A1 PATJ ENPEP RAB11FIP3	2.34e-07	188	205	9	f3edcefeef2ce19086032d98b243c02a6d542b38
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SLC25A42 SLC2A9 MYOM3 SLC13A3 CUBN SLC17A1 PATJ ENPEP RAB11FIP3	2.34e-07	188	205	9	0792432cd4c564dea1102241ea9884f7ced7658c
ToppCell	facs-Aorta-Heart-3m-Mesenchymal-fibroblast\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BNC1 FNDC1 HEG1 PTPRF PTPRS FRAS1 ADGRA2 VCAN SMO	2.67e-07	191	205	9	9214655dca96d766737c9f30b624d7fe7050342e
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	DCHS2 HTR3C BNC1 ACSBG2 USH2A FRAS1 CELA3B BPIFB4 MUC6	2.92e-07	193	205	9	315840bc48899f3a36d57b19197509de19716e3d
ToppCell	RV-10._Endothelium_II\|RV / Chamber and Cluster_Paper	DAPK1 HEG1 HSPG2 DOCK9 HIPK2 PKHD1L1 ARAP3 HMCN1 IL4R	2.92e-07	193	205	9	01c2df9206f1527c578e808978e58196c35e72f5
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FHIP1A FRAS1 SLC13A3 CUBN SLC17A1 PATJ ENPEP CACNA2D3 RAB11FIP3	2.92e-07	193	205	9	82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FHIP1A FRAS1 SLC2A9 SLC13A3 CUBN SLC17A1 PATJ ENPEP RAB11FIP3	3.05e-07	194	205	9	7002937e8903e037332a215d00fbc7c7843b33f2
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	DAPK2 DAPK1 PTPRF PLXNA1 FRAS1 FLVCR2 DENND3 PATJ CACNA2D3	3.78e-07	199	205	9	d43c605a4ff221cf78d91678c15d2ad20f831c7f
ToppCell	LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	DAPK2 DAPK1 PTPRF PLXNA1 FRAS1 FLVCR2 DENND3 PATJ CACNA2D3	3.94e-07	200	205	9	ddfb1f006365bf16203ee49f20200f68220cc288
ToppCell	LPS_IL1RA\|World / Treatment groups by lineage, cell group, cell type	ITGB3 STAT3 HEG1 NFKB2 NFKBIE COL12A1 DOCK9 ENO1 IL4R	3.94e-07	200	205	9	a02fa5b3c4723a6eaa3c685588666c710478dd25
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	RUSC2 TOMM40L AADACL2 ADGRA2 SLC17A5 CELA3B ARAP3 WDFY3	4.42e-07	148	205	8	fd0d8386b94adb1bdc993fbb44d2d87852bfd7f0
ToppCell	PND07-28-samps-Mesenchymal-Mesothelial\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	PHYHIP ADCY9 BNC1 FHIP1A FRAS1 EPB41L4B MUC16 PKHD1L1	6.60e-07	156	205	8	574f761962a7dd3308bd41fc529dd3ea1b8625f8
ToppCell	PND07-28-samps-Mesenchymal-Mesothelial-Mesothelial\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	PHYHIP ADCY9 BNC1 FHIP1A FRAS1 EPB41L4B MUC16 PKHD1L1	6.60e-07	156	205	8	605d95a900e1443d3f6aae163ef2e893d3293203
ToppCell	BAL-Mild-Myeloid-cDC-cDC-cDC_0\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ABL2 TRPS1 ADCY9 DLGAP3 SNX32 NFKB2 VCAN CACNA2D3	7.62e-07	159	205	8	ded4e3626a62fb6334403b7213b467fb7e8131c3
ToppCell	BAL-Mild-Myeloid-cDC-cDC-cDC_0\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	ABL2 TRPS1 ADCY9 DLGAP3 SNX32 NFKB2 VCAN CACNA2D3	7.62e-07	159	205	8	2f6c60ddff2208a68146f9786143d9aefd528840
ToppCell	Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Pdgfa_(Mural.Rgs5Acta2.Pdgfa)-\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	FNDC7 FHIP1A CD300LF PCDHGA7 AOC2 LIPT1 ADAMTS14	1.00e-06	114	205	7	2cc5d2da5573650c5232a01e2d2128082c4bffcb
ToppCell	Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Pdgfa_(Mural.Rgs5Acta2.Pdgfa)\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	FNDC7 FHIP1A CD300LF PCDHGA7 AOC2 LIPT1 ADAMTS14	1.00e-06	114	205	7	fceb7cc590a47380145fc0d854c9f2350dbb0a59
ToppCell	wk_15-18-Epithelial-Airway_epithelial_progenitor-epi-prox-progenitor_intermediate_\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	DAPK2 DAPK1 PTPRF ZNF608 FHIP1A FRAS1 SUSD4 MUC6	1.01e-06	165	205	8	f6887c64af0f26e33316bc5587487e24d76ece2a
ToppCell	B_cells-pDCs\|World / Immune cells in Kidney/Urine in Lupus Nephritis	MAP1A CADM4 PTPRS SCN9A FHIP1A HSPG2 TGFBI DNAH12	1.15e-06	168	205	8	dc8f94424f60ab56facdcffa969e7f3466ee1b6e
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SLC25A42 SLC2A9 MYOM3 SLC13A3 CUBN SLC17A1 ENPEP RAB11FIP3	1.32e-06	171	205	8	f5014e3c387fe3118944af392abe10d6b9b0abab
ToppCell	facs-Marrow-B-cells-24m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	WDR89 USH2A SYT13 FRAS1 COL12A1 HMCN1 PAX5 CACNA2D3	1.57e-06	175	205	8	887e75fc90e59a6394d62f3c048a9cfdf6707725
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DAPK2 PTPRF FHIP1A FRAS1 EPB41L4B DENND3 PATJ CACNA2D3	1.86e-06	179	205	8	04ce3673e46606f63d9c87bcba3a64c96817d812
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MCF2L SLC25A42 SLC2A9 SLC13A3 CUBN SLC17A1 ENPEP RAB11FIP3	1.94e-06	180	205	8	f8bdfd7bf7b3d52c659a29d8f5f80858e79da83e
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SCN9A SLC25A42 SLC2A9 SLC13A3 CUBN SLC17A1 ENPEP RAB11FIP3	1.94e-06	180	205	8	1363b3254470f6ff98630d1df83a1bdbacc137e0
ToppCell	3'_v3-blood-Myeloid_Dendritic-pDC\|blood / Manually curated celltypes from each tissue	HIVEP1 MAP1A CADM4 DAPK1 PTPRS SCN9A RAB40B FHIP1A	2.02e-06	181	205	8	66d890a105f955dca91d6e5e6c730d1a68ee9233
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DAPK1 RIPOR3 FRAS1 COL12A1 HIPK2 RGS12 PATJ CACNA2D3	2.02e-06	181	205	8	9d782ba5cf5a172cb4f447763fc50e5b13ef7dd9
ToppCell	COVID-19-kidney-PCT-S1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	FRAS1 SLC2A9 SLC13A3 CUBN SLC17A1 PATJ ENPEP RAB11FIP3	2.19e-06	183	205	8	6878d14026c3df6aa12e45dfad94b32fa9d9b0b7
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MCF2L SLC25A42 SLC2A9 SLC13A3 CUBN SLC17A1 ENPEP RAB11FIP3	2.19e-06	183	205	8	84b64cf728629c3af9a8d2ed15b93adf562c54b8
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MCF2L SLC25A42 SLC2A9 SLC13A3 CUBN SLC17A1 ENPEP RAB11FIP3	2.19e-06	183	205	8	facd6dbe0851b537d70a899ac7485714ab27d071
ToppCell	COVID-19-kidney-PCT-S1\|kidney / Disease (COVID-19 only), tissue and cell type	VPS13A SLC2A9 MYOM3 SLC13A3 CUBN SLC17A1 ENPEP RAB11FIP3	2.28e-06	184	205	8	51ed1ebfdef45149541917c66cbacad87072e51f
ToppCell	PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_C\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	DES FNDC1 AGT COL12A1 TGFBI HMCN1 ADGRG2 CACNA2D3	2.37e-06	185	205	8	427176ad9ab8d9511200fb0a132cfd1e835fe35c
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DAPK2 DAPK1 TC2N PTPRF FHIP1A FRAS1 PATJ CACNA2D3	2.47e-06	186	205	8	4e94158db52df41d71e67b02b9895a358eebee0f
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ADCY9 MCF2L SLC25A42 SLC2A9 SLC13A3 CUBN SLC17A1 RAB11FIP3	2.57e-06	187	205	8	3ae3b8de1a195d4d5057cf3c64fcdb5f48681ce5
ToppCell	COVID-19-kidney-tDL\|kidney / Disease (COVID-19 only), tissue and cell type	ADCY9 VPS13A SLC2A9 SLC13A3 CUBN SLC17A1 ENPEP RAB11FIP3	2.57e-06	187	205	8	d35d27ca3c0e65f92f4508e1cb98a743f44fdcdf
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DAPK2 DAPK1 PTPRF FHIP1A FRAS1 NIBAN2 PATJ CACNA2D3	2.57e-06	187	205	8	58d48128547ee3513d0bf7f78e61b76b1c472ca9
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MCF2L SLC25A42 SLC2A9 SLC13A3 CUBN SLC17A1 ENPEP RAB11FIP3	2.57e-06	187	205	8	dcf6475ece5b34d9d58a0d1f51c18acedb19c119
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MCF2L SLC25A42 SLC2A9 SLC13A3 CUBN SLC17A1 ENPEP RAB11FIP3	2.57e-06	187	205	8	f1356273bd3587b6883295edf15cb9cdb706c057
ToppCell	RA-10._Endothelium_II\|World / Chamber and Cluster_Paper	DAPK1 HSPG2 DOCK9 HIPK2 PKHD1L1 HMCN1 VCAN IL4R	2.78e-06	189	205	8	75c248b9de5e2fb7a0baa8cdbab516e575cc4394
ToppCell	COVID-19-kidney-PCT-S2\|kidney / Disease (COVID-19 only), tissue and cell type	SLC2A9 MYOM3 SLC13A3 CUBN SLC17A1 PATJ ENPEP RAB11FIP3	2.78e-06	189	205	8	0be5c669b6b308bd98ddb70c84877c62a6244bbd
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF608 SLC2A9 MYOM3 FLVCR2 CUBN SLC17A1 ENPEP RAB11FIP3	2.89e-06	190	205	8	989d4eefd22d66ecb857836f8fdbcf41e3047f84
ToppCell	facs-Lung-nan-3m-Mesenchymal-pulmonary_interstitial_fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DES AGT SLC25A42 COL12A1 PNMT TGFBI ADGRG2 CACNA2D3	2.89e-06	190	205	8	c7bd087f36321cec61b98657433b4d19d135791f
ToppCell	facs-Lung-nan-3m-Mesenchymal-Myofibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DES AGT SLC25A42 COL12A1 PNMT TGFBI ADGRG2 CACNA2D3	2.89e-06	190	205	8	834218fcc59df5e7e52de154272f3d55d81d0dac
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MCF2L SLC2A9 SLC13A3 CUBN SLC17A1 PATJ ENPEP RAB11FIP3	3.01e-06	191	205	8	1c1d13144259b998d4a0e85142f7afef2ef1e63f
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MCF2L SLC2A9 SLC13A3 CUBN SLC17A1 PATJ ENPEP RAB11FIP3	3.01e-06	191	205	8	3c464645d0e7e423f791bd63bf5bcf11f6b590d3
ToppCell	Healthy-pDC\|World / disease group, cell group and cell class	MAP1A CADM4 DAPK2 PTPRS SCN9A FHIP1A ATP13A2 TGFBI	3.01e-06	191	205	8	6e1d825dc33b915b95f13ccd237a552160a4be98
ToppCell	renal_cortex_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	FRAS1 SLC2A9 SLC13A3 CUBN SLC17A1 SSH2 PATJ RAB11FIP3	3.13e-06	192	205	8	e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCell	Healthy-pDC\|Healthy / disease group, cell group and cell class	MAP1A CADM4 DAPK2 PTPRS SCN9A FHIP1A ATP13A2 TGFBI	3.13e-06	192	205	8	33d695a28d22b4af111df9591830a33bb7ef7b2d
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-E\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	TRPS1 APOBR SLC22A20P NIBAN2 SLA TGFBI FURIN VCAN	3.25e-06	193	205	8	d9bb77214bb92e8392cf74e3bfdf177a96fd71ea
ToppCell	RV-10._Endothelium_II\|World / Chamber and Cluster_Paper	DAPK1 HSPG2 DOCK9 HIPK2 PKHD1L1 ARAP3 HMCN1 IL4R	3.25e-06	193	205	8	2531266bc57339d4e2b22a88817008e32b8c1598
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Gen_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CTNNAL1 HEG1 ZNF608 MCF2L SUSD4 DOCK9 ARAP3 HMCN1	3.25e-06	193	205	8	6e1982d089a9de628e6006d23ff78a223fbd9f47
ToppCell	droplet-Bladder-nan-24m-Epithelial-bladder_mesenchymal_cell_(Car3+)\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IRGM FNDC1 HSPG2 COL12A1 TGFBI VCAN ENPEP IL4R	3.25e-06	193	205	8	2d891c00b8f0aace17d4c300b63e2341dcffa199
ToppCell	LV-10._Endothelium_II\|LV / Chamber and Cluster_Paper	HEG1 HSPG2 DOCK9 HIPK2 PKHD1L1 ARAP3 HMCN1 IL4R	3.38e-06	194	205	8	b6cc849fa08599bff9839ef382d190cc964e273e
ToppCell	facs-Lung-3m-Mesenchymal-myofibroblast-myofibroblast_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DES AGT SLC25A42 COL12A1 PNMT TGFBI ADGRG2 CACNA2D3	3.51e-06	195	205	8	c6bb16c0076639c6ddef1a15d8cba44bc29c077d
ToppCell	facs-Lung-3m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DES AGT SLC25A42 COL12A1 PNMT TGFBI ADGRG2 CACNA2D3	3.51e-06	195	205	8	ea89f80d3d7e9f737442f7c1aa1791d277ffc90c
ToppCell	PND01-03-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_B\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	FNDC1 AGT COL12A1 TGFBI ADGRG2 VCAN ADAMTS14	3.60e-06	138	205	7	8d70e64843f7c3be8ee4203cc126fdf1001f0df5
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ABL2 APOBR NIBAN2 SLA TGFBI FURIN VCAN ENO1	3.64e-06	196	205	8	a44a648bf209ce037bfc7b3adfcb220aab60728c
ToppCell	PND10-Mesenchymal\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DES FNDC1 AGT TGFBI HMCN1 ADGRG2 VCAN ENPEP	3.64e-06	196	205	8	ace167a40adb7022b365be3c2b1cbd4ba963739a
ToppCell	IPF-Epithelial\|IPF / Disease state, Lineage and Cell class	PTPRF AADACL2 FHIP1A VWA3A EPB41L4B DYNC2H1 DNAH12 PATJ	3.64e-06	196	205	8	87d9881cfec461a5d89b688a83749b618c519485
ToppCell	P03-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	DES FNDC1 AGT COL12A1 TGFBI HMCN1 ADGRG2 ADAMTS14	3.78e-06	197	205	8	2cec938caf6ffd031cea37277071487e59b2c71c
ToppCell	PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DES FNDC1 AGT COL12A1 TGFBI HMCN1 ADGRG2 ADAMTS14	3.78e-06	197	205	8	090a251194da3e2806989d9a522588f83f52da7f
ToppCell	Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT1\|Control_saline / Treatment groups by lineage, cell group, cell type	DAPK2 DAPK1 PTPRF PLXNA1 MICAL1 FRAS1 FLVCR2 DENND3	3.93e-06	198	205	8	85f424cd9bb3117c9e322031024aabb87696ce47
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_only / Treatment groups by lineage, cell group, cell type	MYCBP2 STAT3 DES NFKB2 NFKBIE HIVEP3 VCAN IL4R	4.07e-06	199	205	8	fde2b65afde69f402f1b7b056eaa266e9fd5b227
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	CTNNAL1 HEG1 ZNF608 MCF2L COL12A1 DOCK9 ARAP3 HMCN1	4.23e-06	200	205	8	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuronal-Intermediate\|GW16 / Sample Type, Dataset, Time_group, and Cell type.	HIVEP1 ABL2 DAPK3 SYT13 SUSD4 ZNF540 KCTD3 ENPEP	4.23e-06	200	205	8	a3fcd901cb281920f1bafdfd676399a6dc37355e
ToppCell	Globus_pallidus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Col15a1_(Col15a1)-\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	ABL2 RIPOR3 FNDC7 FHIP1A COL12A1 PAX5	7.78e-06	102	205	6	0bbc6344d0baee47326a16a89773bb5c68a7b040
ToppCell	Globus_pallidus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Col15a1_(Col15a1)\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	ABL2 RIPOR3 FNDC7 FHIP1A COL12A1 PAX5	7.78e-06	102	205	6	11fbdb428824023603e9d4ee41e957ba84e7c29e
ToppCell	Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1\|Hippocampus / BrainAtlas - Mouse McCarroll V32	ABL2 ACSS3 HSPG2 COL12A1 SLC13A3 FLVCR2 TGFBI	9.14e-06	159	205	7	92049a8d8fc9997d8d0d76500c72596a9b2394e0
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	HERC2 MCF2L DOCK9 MYOM3 CUBN PIGU PATJ	9.92e-06	161	205	7	5fba13f0aa5002f7eefe219e2c6a07e163f1a50d
ToppCell	PND10-Endothelial-Endothelial_lymphatic\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CTNNAL1 DAPK2 FZD9 MROH7 SUSD4 PKHD1L1 RAB11FIP3	1.12e-05	164	205	7	f13b8d9b7f42193f333d9a77571a1dde6bbb48d8
ToppCell	PND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CTNNAL1 DAPK2 FZD9 MROH7 SUSD4 PKHD1L1 RAB11FIP3	1.12e-05	164	205	7	4cfc9f92e49f86d3639e018b35b6a60dc62f494a
ToppCell	PND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CTNNAL1 DAPK2 FZD9 MROH7 SUSD4 PKHD1L1 RAB11FIP3	1.12e-05	164	205	7	7a8e5ef52a8fd2877d59ef0696af8a7af90bbed6
ToppCell	PND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CTNNAL1 DAPK2 FZD9 MROH7 SUSD4 PKHD1L1 RAB11FIP3	1.12e-05	164	205	7	5e5bd81414ea2d64f73cdef19a0a78c17bec8c18
ToppCell	PCW_13-14-Hematologic_ErythroMegGranulo-Hem_ErythroMeg-im_megakaryocyte2_(17)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	RIPOR3 ITGB3 TC2N LCN2 SLA PKHD1L1 SLC18A2	1.16e-05	165	205	7	d2ab667ff53f538b12ee4e07ea4b4d118600a228
ToppCell	droplet-Heart-nan-24m-Hematologic-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GMEB2 BLM BRCA1 ABCC10 SLC2A9 DENND3 MARK4	1.26e-05	167	205	7	bad33497ceeab968a7eb8a48b921c6f936390743
ToppCell	10x5'-lymph-node_spleen-Myeloid_Dendritic-pDC\|lymph-node_spleen / Manually curated celltypes from each tissue	MAP1A CADM4 PTPRS SCN9A FHIP1A TGFBI CACNA2D3	1.31e-05	168	205	7	cfed36fece51871a5abbcde71f6bd5e7212357ff
ToppCell	PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MAP1A DES AGT PNMT TGFBI ADGRG2 CACNA2D3	1.36e-05	169	205	7	42a9b8c77d2a4d68b01e4db38f8a1af53c9c814f
ToppCell	5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CCDC8 VWA3A TDRD5 DYNC2H1 CUBN DNAH12 CFAP418	1.36e-05	169	205	7	8bca402e144819cb9a8d431d6bf9429be2fff6d6
ToppCell	PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MAP1A DES AGT PNMT TGFBI ADGRG2 CACNA2D3	1.36e-05	169	205	7	88aa2246ede582c2e11de63228d76f520889ecb3
ToppCell	PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MAP1A DES AGT PNMT TGFBI ADGRG2 CACNA2D3	1.36e-05	169	205	7	a6a5b00912b653fad2ca7f096deaf35c9ef85e5b
ToppCell	facs-Diaphragm-Limb_Muscle-24m\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SCN9A WDR89 USH2A FRAS1 CUBN LCN2 PKHD1L1	1.36e-05	169	205	7	12bdc709bc000d7f9061ecd9fbd57233eaacb7e2
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell_prolif\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	BTNL8 HEG1 DOCK9 PKHD1L1 HIVEP3 ARAP3 IL4R	1.58e-05	173	205	7	f193c63cc536d891c9d23043765e320252bb6e65
ToppCell	CTRL-Lymphoid-pDC\|Lymphoid / Disease state, Lineage and Cell class	MAP1A CADM4 PFAS PTPRS SCN9A FHIP1A TGFBI	1.64e-05	174	205	7	ff4315e9fad198cc323fc987deb8652da137cf98
ToppCell	PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DAPK2 PTPRF ABCC10 SUSD4 EPB41L4B AOC2 FLVCR2	1.70e-05	175	205	7	96219e58dcb327fd27190be78193e7a0d611e62b
ToppCell	PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DAPK2 PTPRF ABCC10 SUSD4 EPB41L4B AOC2 FLVCR2	1.70e-05	175	205	7	cb974fbebe8cb58c7d3f7defabb4e056f2fee5fa
ToppCell	droplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-leukocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CTNNAL1 DAPK2 ITGB3 TC2N SUSD4 LCN2 PKHD1L1	1.70e-05	175	205	7	f6e1d7297a4dbb38e1ab4f738d91f0e62abaee69
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	WDR89 USH2A FRAS1 COL12A1 HMCN1 PAX5 CACNA2D3	1.77e-05	176	205	7	c6484334187f64cd00cd35e77d8ae436556b4260
Drug	AC1L18ZV	BLM AOC2 ENO1 ENO2 ENO3	4.24e-08	12	205	5	CID000000329
Drug	N-succinylphenylglycine	ENO1 ENO2 ENO3	7.19e-07	3	205	3	CID000448582
Drug	AC1MOUJL	ENO1 ENO2 ENO3	7.19e-07	3	205	3	CID003400924
Drug	C03356	ENO1 ENO2 ENO3	7.19e-07	3	205	3	CID000439988
Drug	3-bromo-2-(bromomethyl)propionic acid	ENO1 ENO2 ENO3	7.19e-07	3	205	3	CID000318915
Drug	C04309	ENO1 ENO2 ENO3	7.19e-07	3	205	3	CID000440293
Drug	2,3-diketo-1-phosphohexane	ENO1 ENO2 ENO3	7.19e-07	3	205	3	CID000192519
Drug	Fillalbin [4540-25-4]; Down 200; 13.8uM; PC3; HT_HG-U133A	DAPK3 ADCY9 RUSC2 MCF2L WDR62 BRSK2 RGS12 TGFBI SLC18A2 MARK4 ENO3	1.66e-06	195	205	11	4092_DN
Drug	dimethyl chlorophosphate	ENO1 ENO2 ENO3	2.86e-06	4	205	3	CID000101863
Drug	[2-(oxidoamino)-2-oxoethyl]phosphonic acid	ENO1 ENO2 ENO3	2.86e-06	4	205	3	CID011969443
Drug	3-aminoenolpyruvate-2-phosphate	ENO1 ENO2 ENO3	2.86e-06	4	205	3	CID003037152
Drug	2-ptz	ENO1 ENO2 ENO3	2.86e-06	4	205	3	CID000445375
Drug	tricyclohexylammonium	ENO1 ENO2 ENO3	2.86e-06	4	205	3	CID000226271
Drug	saracatinib	SRMS STAT3 AGT MTOR AIFM1	3.87e-06	27	205	5	CID010302451
Drug	tetrahydroaldosterone-3-glucuronide	STAT3 DES ENO1 ENO2 ENO3	5.61e-06	29	205	5	CID000167918
Drug	N-methylacrylamide	ENO1 ENO2 ENO3	7.10e-06	5	205	3	CID000014471
Drug	AC1L1CAI	ENO1 ENO2 ENO3	7.10e-06	5	205	3	CID000000145
Drug	tartronate semialdehyde phosphate	ENO1 ENO2 ENO3	7.10e-06	5	205	3	CID000151938
Drug	2-phospho-3-butenoic acid	ENO1 ENO2 ENO3	7.10e-06	5	205	3	CID000191423
Drug	1-Pdmsp	ENO1 ENO2 ENO3	7.10e-06	5	205	3	CID000000561
Drug	BMS-345541	STAT3 NFKB2 MAP3K14 RELA AIFM1	9.31e-06	32	205	5	CID009813758
Drug	Niclosamide	CYP1A2 UNC93A ITGB3 STAT3 FZD9 RELA MTOR AIFM1 ENO2 ENO3	9.59e-06	191	205	10	ctd:D009534
Drug	Freon 22	ITGB3 ENO1 ENO2 ENO3	1.07e-05	16	205	4	CID000006372
Drug	Cyclobenzaprine hydrochloride [6202-23-9]; Up 200; 12.8uM; PC3; HT_HG-U133A	DAPK3 HEG1 HTR1D SLC2A9 RGS12 DENND3 SLC17A5 TRIB3 MARK4 PAX5	1.20e-05	196	205	10	4252_UP
Drug	dimidium	ENO1 ENO2 ENO3	1.41e-05	6	205	3	CID000068207
Drug	Z(2-Cl)-OSu	ENO1 ENO2 ENO3	1.41e-05	6	205	3	CID000580665
Drug	4-(N,N-dimethylamino)cinnamoyl-CoA	ENO1 ENO2 ENO3	1.41e-05	6	205	3	CID000445461
Drug	AC1L1A7Z	AOC2 ENO1 ENO2 ENO3	1.77e-05	18	205	4	CID000000874
Drug	purpurin-18	EXOSC3 ENO1 ENO2 ENO3	2.23e-05	19	205	4	CID005489047
Drug	iomeprol	STAT3 RELA LCN2	2.45e-05	7	205	3	ctd:C057937
Drug	N-tert-butylacrylamide	ENO1 ENO2 ENO3	2.45e-05	7	205	3	CID000007877
Drug	glycidol phosphate	ENO1 ENO2 ENO3	2.45e-05	7	205	3	CID000152659
Drug	lavendustin C6	ENO1 ENO2 ENO3	2.45e-05	7	205	3	CID000126839
Drug	CPEP	ENO1 ENO2 ENO3	2.45e-05	7	205	3	CID000360637
Drug	enoxacin	CYP1A2 ENO1 ENO2 ENO3	2.76e-05	20	205	4	CID000003229
Drug	macrophomate	ENO1 ENO2 ENO3	3.90e-05	8	205	3	CID010889109
Drug	losartan	CYP1A2 ITGB3 ACTL7A FAT2 AGT HSPG2 COL12A1 COL17A1 PNMT HAT1 TGFBI VCAN ENPEP	4.14e-05	378	205	13	CID000003961
Drug	AC1L19IJ	ENO1 ENO2 ENO3	5.81e-05	9	205	3	CID000000562
Drug	AC1L1A4W	ENO1 ENO2 ENO3	5.81e-05	9	205	3	CID000000837
Drug	3-isoreserpine	ADCY9 VPS13A ABCD4 ABCC10 HTR1D PNMT SLC17A5 SF3B3 SLC18A2	5.88e-05	190	205	9	CID000005052
Drug	Iopanoic acid [96-83-3]; Down 200; 7uM; MCF7; HT_HG-U133A	DAPK3 RUSC2 MCF2L AOC2 TGFBI MARK4 WDFY3 PATJ ENPEP	6.91e-05	194	205	9	5448_DN
Drug	IN1076	SRMS ITGB3 STAT3 MTOR ENO1 ENO2 ENO3	7.06e-05	112	205	7	CID000005309
Drug	Harmaline hydrochloride dihydrate [6027-98-1]; Up 200; 14uM; MCF7; HT_HG-U133A	SLC17A2 APOBR MCF2L HSPG2 HIPK2 RGS12 MARK4 PAX5 IL4R	7.19e-05	195	205	9	2805_UP
Drug	6-mercaptopurine monohydrate; Down 200; 10uM; PC3; HG-U133A	CTNNAL1 TRPS1 BRCA1 MCF2L HIPK2 HIVEP3 ARHGAP5 SMO RAB11FIP3	7.19e-05	195	205	9	667_DN
Drug	Piroxicam [36322-90-4]; Down 200; 12uM; PC3; HT_HG-U133A	DAPK3 RUSC2 BNC1 NFKB2 PLXNA1 HIPK2 ATP13A2 DENND3 SLC17A5	7.47e-05	196	205	9	2089_DN
Drug	Salbutamol [18559-94-9]; Down 200; 16.8uM; MCF7; HT_HG-U133A	DAPK3 DYNC2H1 DOCK9 SLC17A5 SF3B3 MARK4 WDFY3 ENPEP IL4R	7.77e-05	197	205	9	2306_DN
Drug	Nefopam hydrochloride [23327-57-3]; Up 200; 13.8uM; MCF7; HT_HG-U133A	ITGB3 PTPRS ACSBG2 WDR62 HIPK2 ADGRA2 DENND3 VCAN DDX28	7.77e-05	197	205	9	3627_UP
Drug	Gliclazide [21187-98-4]; Up 200; 12.4uM; PC3; HT_HG-U133A	MAP1A ADCY9 SCN9A MCF2L DOCK9 PBRM1 SLC18A2 PATJ RAB11FIP3	7.77e-05	197	205	9	5089_UP
Drug	HQ-cysteine	AIFM1 ENPEP	8.07e-05	2	205	2	CID000161996
Drug	Guanabenz acetate [23256-50-0]; Up 200; 13.8uM; MCF7; HT_HG-U133A	ITGB3 DES HEG1 PTPRS HIVEP3 TGFBI VCAN MARK4 PATJ	8.08e-05	198	205	9	1544_UP
Drug	Mifepristone [84371-65-3]; Up 200; 9.4uM; MCF7; HT_HG-U133A	IMPG1 MAP1A APOBR ITGB3 RUSC2 ABCD4 ACSBG2 DYNC2H1 VCAN	8.08e-05	198	205	9	3185_UP
Drug	pefloxacin	CYP1A2 ENO1 ENO2 ENO3	8.17e-05	26	205	4	CID000051081
Drug	pyrene-4,5-dione	ENO1 ENO2 ENO3	8.24e-05	10	205	3	CID000160814
Drug	L-fuconic acid	ENO1 ENO2 ENO3	8.24e-05	10	205	3	CID000345732
Drug	phosphoenolthiopyruvate	ENO1 ENO2 ENO3	8.24e-05	10	205	3	CID000194910
Drug	xylonate	ENO1 ENO2 ENO3	8.24e-05	10	205	3	CID000010264
Drug	15(S)-15-methyl Prostaglandin E2; Down 200; 10uM; PC3; HT_HG-U133A	ITGB3 RUSC2 HEG1 WDR62 HHLA1 HIVEP3 ARAP3 VCAN WDFY3	8.40e-05	199	205	9	7494_DN
Drug	Calciferol [50-14-6]; Down 200; 10uM; HL60; HT_HG-U133A	CYP1A2 TRPS1 RUSC2 DES PLXNA1 DYNC2H1 MAP3K14 FLVCR2 HIVEP3	8.40e-05	199	205	9	2442_DN
Drug	Amiloride hydrochloride dihydrate [17440-83-4]; Up 200; 13.2uM; MCF7; HT_HG-U133A	OR7E24 CADM4 DAPK2 DAPK3 ITGB3 DOCK9 ADGRA2 DENND3 RAB11FIP3	8.73e-05	200	205	9	4109_UP
Drug	AC1NBU2S	NOP9 NFKB2 AGT RELA ADGRA2 AIFM1 CACNA2D3	9.30e-05	117	205	7	CID004473765
Drug	Chalcone	CYP1A2 STAT3 HAT1 RELA	9.52e-05	27	205	4	ctd:D002599
Drug	allo-threonine	SPNS1 DAPK1 DAPK3 TRIB3 ENO1 ENO2 ENO3	1.04e-04	119	205	7	CID000000205
Drug	SM 164	NFKB2 MAP3K14 RELA	1.13e-04	11	205	3	ctd:C533467
Drug	candesartan	SLC17A2 ITGB3 NFKB2 AGT HAT1 RELA SLC17A1 ENPEP	1.14e-04	162	205	8	CID000002541
Drug	Glu-Ala	ENO1 ENO2 ENO3 ENPEP	1.27e-04	29	205	4	CID000100098
Drug	1-phenylpentan-3-amine	DES ENO1 ENO2 ENO3	1.27e-04	29	205	4	CID005195771
Drug	mucic acid	CYP1A2 SLC17A5 SLC17A1 ENO1 ENO2 ENO3	1.45e-04	88	205	6	CID000000607
Drug	nicaraven	SPNS1 MCF2L MAP3K14 MTOR	1.46e-04	30	205	4	CID000071234
Drug	LG61	ENO1 ENO2 ENO3	1.49e-04	12	205	3	CID000520177
Disease	cortical thickness	MYCBP2 MARK3 TRPS1 MBD6 STAU1 FZD9 BNC1 PTPRF ABCC10 HSPG2 COL12A1 HTR1D DOCK9 SLA ADGRA2 ATP13A2 DENND3 FURIN VCAN KCTD3 SSH2 CACNA2D3	5.42e-06	1113	196	22	EFO_0004840
Disease	Exocrine pancreatic insufficiency	CELA3B MTOR	4.39e-05	2	196	2	C0267963
Disease	Carcinoma	TRPS1 STAT3 BLM DES BRCA1 FURIN ENO1	1.18e-04	164	196	7	C0007097
Disease	1,3,7-trimethylurate measurement	CYP1A2 PTPRF FRAS1	1.24e-04	15	196	3	EFO_0021172
Disease	mean arterial pressure	SLC17A2 CYP1A2 DAPK1 AGT ABCC10 HECTD4 HIPK2 HIVEP3 ARAP3 FURIN MARK4 ENPEP	1.38e-04	499	196	12	EFO_0006340
Disease	visual impairment and progressive phthisis bulbi (implicated_via_orthology)	MARK3 MARK4	2.61e-04	4	196	2	DOID:0070356 (implicated_via_orthology)
Disease	neuroimaging measurement	CYP1A2 DCHS2 CTNNAL1 MARK3 TRPS1 MBD6 ARHGEF11 FZD9 BRCA1 HTR1D DOCK9 BRSK2 SLC13A3 ATP13A2 DENND3 FURIN VCAN SSH2	2.97e-04	1069	196	18	EFO_0004346
Disease	Animal Mammary Neoplasms	TRPS1 STAT3 DES BRCA1 FURIN ENO1	3.85e-04	142	196	6	C0024667
Disease	Mammary Carcinoma, Animal	TRPS1 STAT3 DES BRCA1 FURIN ENO1	3.85e-04	142	196	6	C1257925
Disease	Neurodevelopmental Disorders	BRSK2 HIVEP3 PAX5 WDFY3 CACNA2D3	3.98e-04	93	196	5	C1535926
Disease	Agents acting on the renin-angiotensin system use measurement	CYP1A2 TRPS1 ADCY9 AGT ABCC10 HIPK2 RGS12 SF3B3 ENPEP	4.30e-04	335	196	9	EFO_0009931
Disease	primary progressive multiple sclerosis (is_implicated_in)	ADAMTS14 IL4R	4.33e-04	5	196	2	DOID:0050784 (is_implicated_in)
Disease	Ureteral obstruction	AGT HIPK2 RELA	5.27e-04	24	196	3	C0041956
Disease	pancreatic cancer (is_marker_for)	MUC16 RELA SMO MUC6 IL4R	5.81e-04	101	196	5	DOID:1793 (is_marker_for)
Disease	Mammary Neoplasms, Experimental	TRPS1 STAT3 DES BRCA1 FURIN ENO1	6.12e-04	155	196	6	C0024668
Disease	Liver Cirrhosis, Experimental	SLC17A2 CYP1A2 ITGB3 AGT NFKBIE RAB40B COL12A1 RTN4 RELA LCN2 SLA TRIB3 SLC17A1 ENPEP	7.11e-04	774	196	14	C0023893
Disease	Carcinomatosis	TRPS1 STAT3 DES BRCA1 FURIN ENO1	7.97e-04	163	196	6	C0205699
Disease	Carcinoma, Spindle-Cell	TRPS1 STAT3 DES BRCA1 FURIN ENO1	7.97e-04	163	196	6	C0205697
Disease	Undifferentiated carcinoma	TRPS1 STAT3 DES BRCA1 FURIN ENO1	7.97e-04	163	196	6	C0205698
Disease	Anaplastic carcinoma	TRPS1 STAT3 DES BRCA1 FURIN ENO1	7.97e-04	163	196	6	C0205696
Disease	Ulcerative Colitis	IRGM STAT3 HERC2 RELA	8.28e-04	63	196	4	C0009324
Disease	Malignant neoplasm of breast	STAT3 DES NOP9 BRCA1 SNX32 MROH7 HERC2 MICAL1 DYNC2H1 RELA CUBN HELQ PBRM1 ARAP3 MTOR ENO1 ENPEP	8.71e-04	1074	196	17	C0006142
Disease	Colorectal Carcinoma	CYP1A2 HTR3C TOMM40L PTPRS VPS13A ABCD4 RTN4 HAT1 CUBN HIVEP3 ARAP3 ZNF540 DCHS1	8.87e-04	702	196	13	C0009402
Disease	hyperuricemia (implicated_via_orthology)	STAT3 SLC2A9	9.02e-04	7	196	2	DOID:1920 (implicated_via_orthology)
Disease	response to interferon-beta	DENND3 GRHL3	9.02e-04	7	196	2	GO_0035456
Disease	remission	HSPG2 CELA3B	9.02e-04	7	196	2	EFO_0009785
Disease	Ischemic stroke, factor VII measurement	MCF2L HECTD4 PIGU	9.29e-04	29	196	3	EFO_0004619, HP_0002140
Disease	Breast Carcinoma	STAT3 DES NOP9 BRCA1 SNX32 HERC2 DYNC2H1 RELA PBRM1 MTOR ENO1	1.00e-03	538	196	11	C0678222
Disease	Ovarian Mucinous Adenocarcinoma	DAPK3 MAP3K14 MTOR	1.13e-03	31	196	3	C1335167
Disease	renal cell carcinoma (is_implicated_in)	STAT3 RELA PBRM1 IL4R	1.17e-03	69	196	4	DOID:4450 (is_implicated_in)
Disease	monocyte percentage of leukocytes	MARK3 TRPS1 ARHGEF11 ADCY9 BRCA1 NFKBIE CFAP206 MAP3K14 CELA3B DNAH12 MARK4 WDFY3 SSH2	1.28e-03	731	196	13	EFO_0007989
Disease	Brain Tumor, Primary	DAPK1 RELA SMO	1.36e-03	33	196	3	C0750974
Disease	Primary malignant neoplasm of brain	DAPK1 RELA SMO	1.36e-03	33	196	3	C0750979
Disease	Recurrent Brain Neoplasm	DAPK1 RELA SMO	1.36e-03	33	196	3	C0750977
Disease	Benign neoplasm of brain, unspecified	DAPK1 RELA SMO	1.36e-03	33	196	3	C0496899
Disease	Neoplasms, Intracranial	DAPK1 RELA SMO	1.36e-03	33	196	3	C1527390
Disease	joint hypermobility measurement	FNDC1 COL12A1 VCAN	1.36e-03	33	196	3	EFO_0007905
Disease	mitral valve prolapse (is_implicated_in)	AGT DCHS1	1.53e-03	9	196	2	DOID:988 (is_implicated_in)
Disease	Sarcomatoid Renal Cell Carcinoma	DAPK1 RELA PBRM1 MTOR IL4R	1.68e-03	128	196	5	C1266043
Disease	Chromophobe Renal Cell Carcinoma	DAPK1 RELA PBRM1 MTOR IL4R	1.68e-03	128	196	5	C1266042
Disease	Collecting Duct Carcinoma of the Kidney	DAPK1 RELA PBRM1 MTOR IL4R	1.68e-03	128	196	5	C1266044
Disease	Papillary Renal Cell Carcinoma	DAPK1 RELA PBRM1 MTOR IL4R	1.68e-03	128	196	5	C1306837
Disease	Renal Cell Carcinoma	DAPK1 RELA PBRM1 MTOR IL4R	1.68e-03	128	196	5	C0007134
Disease	Atrophic	CYP1A2 STAT3	1.91e-03	10	196	2	C0333641
Disease	Malignant neoplasm of brain	DAPK1 RELA SMO	2.05e-03	38	196	3	C0153633
Disease	colon cancer (biomarker_via_orthology)	STAT3 LCN2 MTOR	2.21e-03	39	196	3	DOID:219 (biomarker_via_orthology)
Disease	Brain Neoplasms	DAPK1 RELA SMO	2.21e-03	39	196	3	C0006118
Disease	forced expiratory volume, body mass index	HECTD4 PCDHA1	2.32e-03	11	196	2	EFO_0004314, EFO_0004340
Disease	Inherited neuropathies	KCNC3 SCN9A TDP1	2.38e-03	40	196	3	C0598589
Disease	Schizophrenia	CYP1A2 CSMD2 ARHGEF11 ITGB3 BRCA1 RTN4 RELA LCN2 RGS12 PBRM1 WDR11 MTOR SLC18A2 ENO2	2.44e-03	883	196	14	C0036341
Disease	retinal vasculature measurement	CYP1A2 HERC2 SYT13 HSPG2 HIPK2 NIBAN2 FLVCR2 DENND3 CELA3B PATJ	2.52e-03	517	196	10	EFO_0010554
Disease	Neoplasm of uncertain or unknown behavior of breast	BRCA1 HERC2 PBRM1	2.56e-03	41	196	3	C0496956
Disease	Breast adenocarcinoma	BRCA1 HERC2 PBRM1	2.56e-03	41	196	3	C0858252
Disease	Nodular glomerulosclerosis	AGT RELA TGFBI	2.56e-03	41	196	3	C0017667
Disease	uric acid measurement	SPNS1 ADCY9 FRAS1 SLC2A9 DYNC2H1 HECTD4 CUBN NSUN3 SLC17A1 MARK4 CACNA2D3	2.68e-03	610	196	11	EFO_0004761
Disease	hyperinsulinism (is_implicated_in)	PTPRF AGT	2.77e-03	12	196	2	DOID:2018 (is_implicated_in)
Disease	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	STAT3 PAX5	2.77e-03	12	196	2	C0023485
Disease	eye color	HERC2 MUC16 HIVEP3 ENPEP	3.09e-03	90	196	4	EFO_0003949
Disease	Diabetic Nephropathy	AGT RELA TGFBI	3.13e-03	44	196	3	C0011881
Disease	Conventional (Clear Cell) Renal Cell Carcinoma	DAPK1 RELA PBRM1 MTOR IL4R	3.16e-03	148	196	5	C0279702
Disease	juvenile polyposis syndrome (implicated_via_orthology)	HIVEP1 HIVEP3	3.26e-03	13	196	2	DOID:0050787 (implicated_via_orthology)
Disease	skin melanoma (is_marker_for)	STAT3 AGT	3.26e-03	13	196	2	DOID:8923 (is_marker_for)
Disease	Acute Promyelocytic Leukemia	DAPK2 STAT3 SMO	3.55e-03	46	196	3	C0023487
Disease	vital capacity	SLC17A2 STAU1 PLXNA1 HSPG2 MICAL1 SLC2A9 EPB41L4B MAP3K14 PCDHA1 PIGU ATP13A2 KCNH3 CELA3B HMCN1 AIFM1 PATJ CACNA2D3	3.78e-03	1236	196	17	EFO_0004312
Disease	gastric ulcer (implicated_via_orthology)	AGT MUC6	3.79e-03	14	196	2	DOID:10808 (implicated_via_orthology)
Disease	Malformations of Cortical Development	WDR62 MTOR	3.79e-03	14	196	2	C1955869
Disease	trimethylamine-N-oxide measurement	RTN4 CUBN	3.79e-03	14	196	2	EFO_0010541
Disease	neuronal ceroid lipofuscinosis (implicated_via_orthology)	SPNS1 ATP13A2	3.79e-03	14	196	2	DOID:14503 (implicated_via_orthology)
Disease	actinic keratosis	TRPS1 HERC2	3.79e-03	14	196	2	EFO_0002496
Disease	Cortical Dysplasia	WDR62 MTOR	3.79e-03	14	196	2	C0431380
Disease	brain measurement, neuroimaging measurement	DCHS2 MARK3 TRPS1 MBD6 BRSK2 ATP13A2 DENND3 PBRM1 VCAN SSH2	3.91e-03	550	196	10	EFO_0004346, EFO_0004464
Disease	Non-Small Cell Lung Carcinoma	DAPK1 STAT3 MTOR ENO1 ENO2	3.95e-03	156	196	5	C0007131
Disease	transient cerebral ischemia (biomarker_via_orthology)	ITGB3 AGT LCN2 MTOR AIFM1	4.06e-03	157	196	5	DOID:224 (biomarker_via_orthology)
Disease	birth weight, pelvic organ prolapse	DOCK9 ARAP3 CACNA2D3	4.25e-03	49	196	3	EFO_0004344, EFO_0004710
Disease	Nephrosis	DES AGT	4.35e-03	15	196	2	C0027720
Disease	chenodeoxycholate measurement	SLC22A20P HMCN1	4.35e-03	15	196	2	EFO_0010471
Disease	blood cobalt measurement	USH2A SLC2A9 MUC16 ADAMTS14	4.67e-03	101	196	4	EFO_0007577
Disease	gout, hyperuricemia	SLC2A9 NSUN3	4.95e-03	16	196	2	EFO_0004274, EFO_0009104
Disease	neutrophil count	HIVEP1 MYCBP2 RIPOR3 BRCA1 SNX32 CD300LF DYNC2H1 HECTD4 PCDHA1 LCN2 HIVEP3 CELA3A SLC25A1 FURIN MARK4 SSH2 MFSD13A ENO1	5.11e-03	1382	196	18	EFO_0004833
Disease	glucose-dependent insulinotropic peptide measurement	SLC41A3 SLC13A3 CACNA2D3	5.30e-03	53	196	3	EFO_0008464
Disease	serum alanine aminotransferase measurement	MARK3 TRPS1 SRMS FZD9 COL12A1 EPB41L4B HECTD4 PIGU RGS12 NSUN3 MARK4 GRHL3 PATJ	5.58e-03	869	196	13	EFO_0004735
Disease	Hepatomegaly	CYP1A2 DAPK2 RELA	5.58e-03	54	196	3	C0019209
Disease	pre-malignant neoplasm (biomarker_via_orthology)	STAT3 SMO	5.59e-03	17	196	2	DOID:0060071 (biomarker_via_orthology)
Disease	Leukemia, Myelocytic, Acute	DAPK1 STAT3 BLM BRCA1 ENO2	6.10e-03	173	196	5	C0023467
Disease	ovarian cancer (is_implicated_in)	STAT3 BRCA1 MUC16	6.18e-03	56	196	3	DOID:2394 (is_implicated_in)
Disease	peak expiratory flow	CYP1A2 PTPRF MLLT6 MICAL1 DOCK9 PIGU ATP13A2 SSH2 CACNA2D3	6.32e-03	498	196	9	EFO_0009718
Disease	Alzheimer's disease (implicated_via_orthology)	HIVEP1 TOMM40L HIVEP3	6.49e-03	57	196	3	DOID:10652 (implicated_via_orthology)

Protein segments in the cluster

Peptide	Gene	Start	Entry
AGAGEVLLSISYLPA	SYT13	286	Q7L8C5
ALYTTSSGGPEDIVL	TDRD5	676	Q8NAT2
SLDIPIGELYGLSES	ACSBG2	411	Q5FVE4
LPLSNLYETLGVVGS	TGFBI	101	Q15582
LPGTSYEELLSLLRG	COL17A1	1156	Q9UMD9
ITYILLSGASPFLGD	DAPK1	206	P53355
LSLESPLLGAGIYTS	MLLT6	541	P55198
LGPLYTNITADIGTD	B4GALT3	331	O60512
ILGGLSYSLPGLTDS	AADACL2	301	Q6P093
GYASLELPGDSTLLS	ARAP3	246	Q8WWN8
LTDSTGVILSQSYPG	CSMD2	2361	Q7Z408
FPYSGDKILVEGIST	VCAN	656	P13611
ESSPGQLSISLRYEG	ABL2	201	P42684
VSALGSVPLISITGY	BTNL8	131	Q6UX41
GILGSVQYTFSSLPL	BPIFB4	356	P59827
GGILASIYLPKSLTE	ADGRG4	2601	Q8IZF6
SLYSPGVQLGALVTT	ADGRA2	1011	Q96PE1
GYEAIGLVDSSLPTV	AIFM1	491	O95831
TIILTISPDNYGLGS	ADGRG2	751	Q8IZP9
SLESYNSGPLSEGTI	BNC1	841	Q01954
SGAYVALTLLGSSPS	ARHGEF11	111	O15085
LFGTYLTKNGSEIPS	ARL9	156	Q6T311
SIEGLGKSCSPVYLG	CFAP418	96	Q96NL8
TPSGLTAYISSEGRI	HTR3C	136	Q8WXA8
GVYGDLSPAELSTLV	ABCD4	296	O14678
FLLTEGRPGYLEIST	DENND3	746	A2RUS2
PSGASTGIYEALELR	ENO2	36	P09104
LSGKLSDYGVTVPCS	ADAMTS14	31	Q8WXS8
SPTAVFGTLASLYLG	AGT	126	P01019
SYVLLRSGLGSPTDI	CFAP206	136	Q8IYR0
PLLGGYTVLASSGST	GMEB2	426	Q9UKD1
SYVTLIPGSSYGISL	MROH7	296	Q68CQ1
TQYLLTLLETDGGLP	R3HDM4	76	Q96D70
PAGIDYKTTTILLDG	RAB40B	46	Q12829
SLYNITLKATDGGTP	PCDHGA7	416	Q9Y5G6
SLSGAGSYLALPALT	HSPG2	3931	P98160
DLTKYLDPSGLGVIS	RAB11FIP3	241	O75154
KGRPDLYTSTLITDG	CYP1A2	106	P05177
YLELIGNSLPGTTAK	NIBAN2	131	Q96TA1
IVTGRDLASTTLPGY	PAX5	301	Q02548
ELLGGPSLRSAYITS	KCNH3	441	Q9ULD8
TIFALAYVLLTSPGG	AOC2	16	O75106
LVPSYTGGSLLEDLA	MBD3L1	96	Q8WWY6
TGYSLATSQVTLPLG	MUC16	9666	Q8WXI7
KDIGVISLPYTSNGL	MUC6	116	Q6W4X9
PGLVGLSLSYALSLT	ABCC10	1181	Q5T3U5
TILYTLTGPGSELFS	DCHS1	1251	Q96JQ0
EGAVLYISPSGTELS	MBD6	31	Q96DN6
PGGILVYSTCTLSKA	NSUN3	256	Q9H649
YLSTRGSSVDGSPLL	NOP9	306	Q86U38
GTVTEGSSPAYLKEI	PBRM1	171	Q86U86
PSYGTLLRISGSEVE	FRAS1	1756	Q86XX4
TQGLPAEYLLSAGTK	HIPK2	416	Q9H2X6
LSSKGSSGAPVYVDL	MAP1A	2681	P78559
SYTLVSKLGLPSEGI	MAGEB6	261	Q8N7X4
LISKLYPGESIGQTS	HERC2	1061	O95714
IPTSDYSAISQLALG	IMPG1	481	Q17R60
TVPGATSYLLTAEDG	FNDC7	51	Q5VTL7
LRLESPGEASSGLYS	HMCN2	1681	Q8NDA2
GTFLSSLLKSPYQGI	LIPT1	186	Q9Y234
SLTYTLSLLGGPEAE	NFKBIE	216	O00221
LPGTGSATTTLENYL	IRGM	91	A1A4Y4
GEDKSSKGYILPLST	KIAA2026	1606	Q5HYC2
GIYSVTFTLLSGPSR	BRSK2	606	Q8IWQ3
GSGEDLYILTGTVPS	ENDOD1	191	O94919
YSDSLLTLPAIVGIG	PLXNA1	1236	Q9UIW2
KTGVLTVTGPLDYES	FAT2	2221	Q9NYQ8
SYLLPSGGSVTLSES	EEF2KMT	111	Q96G04
ITYILLSGASPFLGE	DAPK3	206	O43293
AAETGSGKTLSYLLP	DDX28	171	Q9NUL7
VGYDLTPDSGTTLRK	DNAH12	786	Q6ZR08
SEILLGYLGVPAASS	MIGA2	561	Q7L4E1
VVAGSDPLGLIAYLS	MICAL1	591	Q8TDZ2
ELTPSSGDGLYLLTM	ENPEP	176	Q07075
LGVTAEYSPASRSLG	HEG1	931	Q9ULI3
ISSGLNILYPGETEI	HECTD4	341	Q9Y4D8
EGLSLLDLGVSPYSG	PIGU	46	Q9H490
GALGDYLSFTIPLGT	PSENEN	86	Q9NZ42
GIPTYVLLNTSGIST	HMCN1	341	Q96RW7
DITTTRYSIGGLSPN	PTPRS	381	Q13332
IDGVILYSLGTSSPF	DCHS2	2911	Q6V1P9
DIGANALLTYTLSPS	PCDHA1	161	Q9Y5I3
DSEGVATLPLSYRLG	FAM171A2	76	A8MVW0
EFTLGNIKSYPGLTS	LCN2	111	P80188
LVPGTDYGTQESISL	BRCA1	771	P38398
QDLEGTPYLESGISL	BRCA1	1556	P38398
TDYVEIGSSSILGSP	CUBN	871	O60494
FVLVPLSGYLVLGSS	FZD9	401	O00144
INSLLSSGEVPGLYT	DYNC2H1	2726	Q8NCM8
PSGASTGIYEALELR	ENO1	36	P06733
YALETGLAGIPSSDS	EXOC5	461	O00471
YGTLTIGTSIDPLSS	ATP13A2	16	Q9NQ11
LATGLSGLYSSLPTK	FHIP1A	246	Q05DH4
SGLYSSLPTKLEEKG	FHIP1A	251	Q05DH4
DPLVDSLGSGIVYSA	IL4R	701	P24394
TLLHTYSVLSPTGGE	HAT1	141	O14929
GPSKLEAGSVDSYLL	GRHL3	151	Q8TE85
ILPFYLEVGLSGLSS	KCNC1	286	P48547
KLTSLDIPATYLTGD	BLM	726	P54132
LLGAISGIASPYTTS	DOCK9	1226	Q9BZ29
SLYLFTRGEGPLKTS	CTNNAL1	606	Q9UBT7
GLSVPLTDQGTTLYL	COL12A1	2191	Q99715
YTDIKGTPFSLGVAL	CACNA2D3	606	Q8IZS8
SPSKGYTLQIFELTG	COL20A1	86	Q9P218
ITYILLSGASPFLGD	DAPK2	216	Q9UIK4
LSSLLLVAVASGYGP	CELA3A	6	P09093
LTYPGDTTSALVDGL	FNDC1	411	Q4ZHG4
GTLTKFTLVLYGTAP	FURIN	561	P09958
SLPKEDISYASLTLG	CD300LF	241	Q8TDQ1
IPGYSRSLTTGQLSD	DLGAP3	451	O95886
TTRTPSSYGAGELLD	DES	76	P17661
LTLPGLVSADNGTYT	CADM4	276	Q8NFZ8
TPANYLIGSLATTDL	HTR1D	71	P28221
PLTAGVIGTTKLLYD	ADCY9	1171	O60503
LSSLLLVAVASGYGP	CELA3B	6	P08861
YPESEGISSGLLNIS	FLVCR2	431	Q9UPI3
VILYTLVSGSLPFDG	MARK3	241	P27448
SLGVILYTLVSGSLP	MARK4	241	Q96L34
TYLTSIPSLQDAGIG	MCF2L	116	O15068
NYSELIPGTTVGVLS	ITGB3	346	P05106
AKIPYVTLSTGGIET	SLC2A9	351	Q9NRM0
IPVAGLSDSGLYTVV	IGFN1	1006	Q86VF2
PSGASTGIYEALELR	ENO3	36	P13929
IYSLPTSGGKTLVAE	HELQ	356	Q8TDG4
PVSYLGSKFLGSDLE	CCDC8	131	Q9H0W5
GLTAPLVTTLGEYST	SLC22A20P	471	A6NK97
ISIPYSASIGGTATL	SLC13A3	236	Q8WWT9
ISYAGAQLGTVISLP	SLC17A5	201	Q9NRA2
EYSLGLTPTGILIFE	EPB41L4B	286	Q9H329
VDVGGSEPASLSYLS	EXOSC3	131	Q9NQT5
VPITSYDTAGSFLLL	KCTD3	316	Q9Y597
LSTGSILLGLSYVAP	MFSD13A	301	Q14CX5
LLTTVGSLLPGITYS	PTPRF	471	P10586
LAGIGYSSAVTPKVL	OR5B17	66	Q8NGF7
ILLGPLSVTGASYVA	OR6A2	211	O95222
LGKSLLTGDYIPGTE	MAP3K14	546	Q99558
VRSIYDDISSPGLGS	NUP35	91	Q8NFH5
TSDEIIGLSYGVVSP	OR13D1	301	Q8NGV5
VGLSPALTAVLYDLS	MTOR	511	P42345
YDLSSAISVLVPLGG	MTA3	246	Q9BTC8
AISLSTGRESYIPGI	SLA	61	Q13239
ALSLGQSTDSLGTYP	SMG8	696	Q8ND04
LTLTEYRLHGTGSLP	RUSC2	841	Q8N2Y8
YLGNLSTVLPTEGTL	RTN4	251	Q9NQC3
PIINYTFTSGLSGVL	HHLA1	211	C9JL84
TPLIQYDTSTGLGLV	USH2A	5006	O75445
YDTSTGLGLVLTTPG	USH2A	5011	O75445
LGEAVTGLLLIYPTS	TEX47	81	Q8TBZ9
YGDTPTVSIKGILTL	TC2N	256	Q8N9U0
GSSYREGLTPVLSLL	RIC8B	356	Q9NVN3
GTGLVGYLSSAVLPS	OR7E24	271	Q6IFN5
SPDIQGIILSSTSYG	SLC17A1	76	Q14916
YPSIGQLKTLDLSGT	PRAMEF20	316	Q5VT98
VTLVANTLGYSDLGP	SCN9A	1271	Q15858
SISYDGTVRKESGIP	TRGV9	71	Q99603
PYLTGLGDLLGSSSV	SLC41A3	446	Q96GZ6
TPGAIGLYTLHVTID	MYCBP2	2416	O75592
IIYTEPVDLSLGTLG	PHYHIP	286	Q92561
PSYTISIVGLSGTEK	ARHGAP5	11	Q13017
AGTTAASLTYPLDLV	SLC25A42	141	Q86VD7
TPQTSLGSLSDLIYA	SEBOX	166	Q9HB31
IRPSESSLGGYSLSV	SRMS	146	Q9H3Y6
LLLPGITGSSQDTYV	ABHD1	126	Q96SE0
PSITGRLDYAGSDLT	ACTL7A	236	Q9Y615
ILYTSGTTGLPKGVI	ACSS3	296	Q9H6R3
SLGTFVSYLLGDAVP	APOBR	21	Q0VD83
IDIGSGPTVYQLLSA	PNMT	76	P11086
YTQASLGLLTPVSGT	TRPS1	806	Q9UHF7
DLSETNVYLIGSTPG	TDP1	346	Q9NUW8
YSLPGTLAKSEILET	ZNF35	91	P13682
NLVSLGYSGSKPDVI	ZNF540	41	Q8NDQ6
GYSGSKPDVITLLEQ	ZNF540	46	Q8NDQ6
LSVYEGDTLLGTASP	VPS13A	2006	Q96RL7
SLTTYGVSELKPAGI	WDFY3	341	Q8IZQ1
IVGYLGSIELPSTSS	RGS12	231	O14924
ARELLYGGTSPTAET	STAU1	456	O95793
YLLPRAGLELTSSEG	SSH2	1356	Q76I76
LGGPRATSILSYLSD	RIPOR3	371	Q96MK2
LSTVLPGLTYLTVAG	SAGE1	551	Q9NXZ1
EASGIYVKSIIPGSA	PATJ	391	Q8NI35
TTLAEKLLGPGVNYS	STAT3	526	P40763
VGPEILSSRASYSGK	TRIB3	226	Q96RU7
SGTGRSYTTDPLLSL	VSTM2B	256	A6NLU5
GVGEASYSTIAPTLI	SPNS1	161	Q9H2V7
LKELSDPAGAIIYTS	PFAS	526	O15067
LPSYDEAVSGGLSAL	SUSD4	376	Q5VX71
SSINYGIILTLIPSG	SLC17A2	96	O00624
PLGSVEKDTGSALSY	HIVEP3	1946	Q5T1R4
YTLIPTSILLGLGAA	UNC93A	91	Q86WB7
GLSSLLYGSIPKAAV	SLC25A1	86	P53007
AISPSQGSYEEGTIL	PKHD1L1	1071	Q86WI1
KTTLIPGGSESLVYT	SF3B3	1106	Q15393
SVLPYGATSTLLAGD	SMO	81	Q99835
EYSKPETGLTLLASA	WDR62	541	O43379
GSLGLAFYLPLVVTT	TMEM81	11	Q6P7N7
KSGIIPGSYSFESVL	UBR3	816	Q6ZT12
SAALYGIPEISSTGK	ZNF608	121	Q9ULD9
YTATLTLGNPDLIGE	TOMM40L	146	Q969M1
CSLGTKEPTYLLGID	WDR89	16	Q96FK6
PLLAVGTSNGSVLVY	WDR11	486	Q9BZH6
DYIPISAALSSLGTQ	SNX32	241	Q86XE0
GVAFLPASISYLIGT	SLC18A2	331	Q05940
YTGPGTVRISLVTKD	RELA	66	Q04206
KLLSPRSLGSTDSGY	HIVEP1	661	P15822
SLPLTYGVASSVGTI	TBRG1	101	Q3YBR2
LEGLYLLTDGKPDTS	VWA3A	1051	A6NCI4
PFYLEVGLSGLSSKA	KCNC3	391	Q14003
PYSLETLKGGTILGT	SLC4A1AP	166	Q9BWU0
PLTYSLEKSVIGSGT	MYOM3	531	Q5VTT5
TSPSGSLLRSYELAG	NFKB2	811	Q00653